05.02.2014 Views

fema trailer mdl no. 1873 formaldehyde p - US District Court ...

fema trailer mdl no. 1873 formaldehyde p - US District Court ...

fema trailer mdl no. 1873 formaldehyde p - US District Court ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

UNITED STATES DISTRICT COURT<br />

EASTERN DISTRICT OF LOUISIANA<br />

NEW ORLEANS DIVISION<br />

IN RE: FEMA TRAILER MDL NO. <strong>1873</strong><br />

FORMALDEHYDE<br />

PRODUCT LIABILITY LITIGATION<br />

SECTION “N-5"<br />

THIS DOCUMENT IS RELATED TO:<br />

Lyndon Wright v. Forest River, Inc., et al.<br />

Case No. 09-2977 (E.D. La.)<br />

JUDGE ENGELHARDT<br />

MAG. JUDGE CHASEZ<br />

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *<br />

PLAINTIFF’S EXHIBIT LIST<br />

NOW INTO COURT, through undersigned counsel, comes Plaintiff, Lyndon Wright,<br />

pursuant to this Ho<strong>no</strong>rable <strong>Court</strong>’s August 2009 Trial Scheduling Order, who hereby submits the<br />

following Exhibit List in connection with the above-captioned matter, to be supplemented by<br />

ongoing production, depositions and discovery:<br />

Exhibit<br />

ID<br />

Plaintiff<br />

’s<br />

Exhibits<br />

Government<br />

al Agency<br />

Reports and<br />

Studies<br />

1. CDC Summary and Interim Report:<br />

VOC and Aldehyde Emissions in Four<br />

FEMA Temporary Housing Unites –<br />

Indoor Environment Department,<br />

Lawrence Berkeley National Laboratory,<br />

8 May, 2008<br />

Category: Exhibit Description: Bates Range:<br />

1<br />

PSC002113 –<br />

PSC002166<br />

2. U.S. Department of Health and Human PSC002167 –


Services and CDC Presentation Titled<br />

“Formaldehyde Levels in Occupied<br />

FEMA-supplied Temporary Housing<br />

Units (THUs) in LA and MS, Winter<br />

2007-2008”<br />

3. CDC Interim findings on Formaldehyde<br />

Levels in FEMA-Supplied Travel<br />

Trailers, Park Models, and Mobile<br />

Homes-February 29, 2008<br />

4. Agency for Toxic Substances and<br />

Disease Registry (ATSDR) “Health<br />

Consultations, Formaldehyde Sampling<br />

at FEMA Temporary Housing Units,<br />

Baton Rouge, Louisiana, February 1,<br />

2007<br />

5. ATSDR October 2007 “An Update and<br />

Revision of ATSDR’s February 2007<br />

Health Consultation: Formaldehyde<br />

Sampling of FEMA Temporary-Housing<br />

Trailers Baton Rouge, Louisiana,<br />

September –October 2006”<br />

6. Statement of Harvey E. Johnson, Jr.,<br />

Acting Deputy Administrator and Chief<br />

Operating Officer for FEMA before the<br />

U.S. Senate Subcommittee on State,<br />

Local, and Private Sector Preparedness<br />

and Integration, March 4, 2008<br />

7. Statement of R. David Paulison, FEMA<br />

Administrator, before the U.S. House of<br />

Representatives Committee on Oversight<br />

and Government Reform, July 19, 2007<br />

8. “Formaldehyde Exposure in Homes: A<br />

Reference for State Officials to Use in<br />

Decision-Making” published in March<br />

2008 by the DHHS, CDC, DHS, FEMA<br />

and the EPA<br />

9. U.S. EPA “Indoor Air Quality” Basic<br />

Information for Formaldehyde-Last<br />

updated November 14, 2007<br />

10. “Formaldehyde Levels in FEMA-<br />

Supplied Trailers-Early Findings from<br />

the Centers for Disease Control and<br />

Prevention”<br />

2<br />

PSC002181<br />

PSC002182 –<br />

PSC002202<br />

PSC002264 –<br />

PSC002277<br />

PSC002278 –<br />

PSC002318<br />

PSC003188 –<br />

PSC003198<br />

PSC003199 –<br />

PSC003207<br />

PSC003208 –<br />

PSC003213<br />

PSC003214 –<br />

PSC003217<br />

PSC003218 –<br />

PSC003219<br />

11. ASTM Standard Test Method for PSC021571 –


Determining<br />

Formaldehyde PSC021582<br />

concentrations in Air and Emission<br />

Rates in Wood Products Using a Large<br />

Chamber (2002)<br />

12. Indoor Air Quality and Health in FEMA PSC021583 –<br />

Temporary Housing for Trailer PSC021584<br />

Residents prepared by CDC<br />

13. Trailer Manufacturers and Elevated PSC024251 –<br />

Formaldehyde Levels Majority Staff PSC024277<br />

Analysis, Committee on Oversight and<br />

government Reform, U.S. House of<br />

Representatives dated on July 9, 2008<br />

14. ASHRAE Handbook, 2007: HVAC<br />

Applications, Chapter One: Residences<br />

DUB002101 –<br />

DUB002107<br />

15. Department of Homeland Security, PSC025938 –<br />

Office of Inspector General: FEMA’s PSC026022<br />

Response to Formaldehyde in Trailers<br />

dated June, 2009<br />

16. Majority Staff Report Subcommittee on<br />

Investigations & Oversight – Committee<br />

PSC002070 –<br />

PSC002112<br />

on Science & Tech<strong>no</strong>logy U.S. House of<br />

Representatives, September 2008,<br />

“Toxic Trailers-Toxic Lethargy: How<br />

the Centers for Disease Control and<br />

Prevention Has Failed to Protect the<br />

Public Health”<br />

17. CDC Interim on CDC Study for<br />

Formaldehyde<br />

LWFR-EXP11-000956-<br />

LWFR-EXP11-000976<br />

18. CDC Final Reports on CDC Study for LWFR-EXP11-000889-<br />

Formaldehyde<br />

LWFR-EXP11-000949<br />

19. Lawrence Berkeley Nation Labs report LWFR-EXP11-001569-<br />

on VOCs in Four Trailers<br />

LWFR-EXP11-001629<br />

20. ATSDR Toxicological Profile for LWFR-EXP11-000294-<br />

Formaldehyde<br />

LWFR-EXP11-000761<br />

21. IARC Mo<strong>no</strong>graphs 2004/2009 To be supplemented<br />

22. ASTDR, Minimal Risk Levels (MRLs) To be supplemented<br />

for Hazardous Substances, 2007<br />

http://www.astdr.cdc.gov/mrls/index.htm<br />

l<br />

23. CDC THU Formaldehyde Test Protocol LWFR-EXP 11-000977 –<br />

LWFR-EXP 11-001012<br />

24. NIOSH, EPA, OSHA, etc. re: To be supplemented<br />

Formaldehyde levels<br />

25. CDC, Final Report on Formaldehyde LWFR-EXP 11-00889 –<br />

3


Levels in FEMA-Supplied Travel LWFR-EXP 11-00949<br />

Trailers, Park Models, and Mobile<br />

Homes; Conclusions; 2008,<br />

http://www.cdc.gov/nceh/ehhe/<strong>trailer</strong>stu<br />

dy/residents.htm<br />

Standards,<br />

Regulations,<br />

and Statutes<br />

25 24 C.F.R. § 3280.309, Health Notice on PSC003147<br />

<strong>formaldehyde</strong> emissions Current through<br />

November 6, 2008<br />

26. 24 C.F.R. Parts 3280 and 3285 LWFR-EXP5-000457-<br />

27. §3280.309 – 24 CFR Ch. XX, Health<br />

Notice on Formaldehyde emissions (4-1-<br />

07)<br />

28. ATSDR Formaldehyde Minimal Risk<br />

Levels and Worksheets – Appendix A<br />

29. U.S. Department of Housing and Urban<br />

Development Rules and Regulations<br />

regarding Formaldehyde, 49 FR 31996<br />

30. California air Resources Board’s<br />

(CARB) Standards<br />

31. Occupational Safety and Health<br />

Administration’s (OSHA) Standards for<br />

Formaldehyde<br />

32. American Conference of Governmental<br />

Industrial Hygienists’ (ACGIH)<br />

Standards for Formaldehyde<br />

33. National Institute of Occupational Safety<br />

and Health’s (NIOSH) Standards for<br />

Formaldehyde<br />

4<br />

LWFR-EXP5-000459<br />

PSC021693 –<br />

PSC021694<br />

PSC003158 –<br />

PSC003172<br />

PSC003173 –<br />

PSC003186<br />

PSC021695 –<br />

PSC021753<br />

PSC021754 –<br />

PSC021772<br />

To be supplemented<br />

PSC024278 –<br />

PSC024358<br />

34. NIOSH Pocket Guide LWFR-EXP3-000257<br />

35. Housing and Urban Development’s To be supplemented<br />

(HUD) Standards for Formaldehyde<br />

(including but <strong>no</strong>t limited to 24 C.F.R. §<br />

3280.308)<br />

36. World Health Organization (WHO) and<br />

Health Canada’s Standards for<br />

Formaldehyde<br />

37. American National Standard (ANSI) for<br />

Medium Density Fiberboard dated<br />

February 4, 1994<br />

PSC024359 –<br />

PSC024361<br />

PSC021773 –<br />

PSC021784<br />

38. American National Standard (ANSI) for PSC021785 –


Particleboard dated February 8, 1999<br />

39. ANSI A119.2, NFPA 1192: Standard on<br />

Recreational Vehicles; 2002 Edition<br />

40. ANSI A119.4, NFPA 1194: Standard on<br />

Recreational Vehicle Parks and<br />

Campgrounds; 2002 Edition<br />

41. ANSI/HPVA HP-1; American National<br />

Standard for Hardwood and Decorative<br />

Plywood<br />

42. Toxicological Profile on Formaldehyde<br />

prepared by ATSDR on July 1999<br />

43. Codes and Standards for Recreational<br />

Vehicles ANSI 119.2, NFPA 1192.<br />

44. Any and all standards adopted and/or in<br />

use from 2005 to present by the<br />

Recreational Vehicle Industry<br />

Association (RVIA)<br />

5<br />

PSC021797<br />

DUB002054 –<br />

DUB002100<br />

PSC021798 –<br />

PSC021817<br />

To be supplemented<br />

PSC024362 –<br />

PSC024829<br />

Including, but <strong>no</strong>t limited<br />

to LWFR-EXP5-000460-<br />

LWFR-EXP5-000461<br />

To be supplemented<br />

45. RVIA Standards LWFR-EXP5-000460-<br />

LWFR-EXP5-000461<br />

46. Building Code of the City of New To be supplemented<br />

Orleans, Louisiana<br />

47 2006 International Building Code LWFR-EXP5-000579-<br />

(excerpts)<br />

LWFR-EXP5-000583<br />

48. 2006 International Residential Code LWFR-EXP5-000584-<br />

LWFR-EXP5-000589<br />

49. ASCE 7 To be supplemented<br />

50. ASTM A-36 To be supplemented<br />

51. FEMA Model Travel Trailer To be supplemented<br />

Procurement Specifications<br />

52. Clean Air Act Extension of 1970 To be supplemented<br />

53. Clean Air Act Amendments of 1990 To be supplemented<br />

54. Dometic Brochure LWSR-EXP10-001334-<br />

LWSR-EXP10-001350<br />

55. New Source Performance Standards To be supplemented<br />

(NSPS)<br />

56. National Emissions Standards for To be supplemented<br />

Hazardous Air Pollutants (NESHAP)<br />

57. National Ambient Air Quality Standards To be supplemented<br />

(NAAQS)<br />

58. OSHA Formaldehyde Standards To be supplemented<br />

59. World Health Organization, 2000, Air To be supplemented<br />

Quality Guidelines for Europe; General<br />

Public


60. Suburban Manufacturing Corporation’s To be supplemented<br />

Manufacturer’s Instructions<br />

61. September 1, 2005, Memo from Doug To be supplemented<br />

Gaeddert to Mike Farrell at NACS<br />

62. National Electrical Code; Article 551 To be supplemented<br />

63. NISOH Pocket Guide to Chemical LWFR-EXP3-000257<br />

Hazards, 2005<br />

64. Excerpts from 2005 Hardwood Plywood To be supplemented<br />

Veneer Association “Where to Buy” pp.<br />

78-84<br />

65. Construction Manuals (Manual of Steel LWFR-EXP5-000457-<br />

Construction, Minimum Design Loads, LWFR-EXP5-000459<br />

Timber Construction Manual)<br />

66. <strong>US</strong>EPA, Indoor Air Quality-Basic To be supplemented<br />

Information-Formaldehyde, Washington<br />

DC, 2007<br />

http://epa.gov/iaq/formalde.html<br />

67. <strong>US</strong>DOL, OSHA, OSHA Formaldehyde To be supplemented<br />

Standards,Washington DC, 2008<br />

http://wvvw.osha.gov/SLTC/formaldehy<br />

de/standards.html<br />

68. World Health Organization, Air Quality To be supplemented<br />

Guidelines for Europe-Formaldehyde,<br />

Copenhagen, DE, 2001<br />

http://www.euro.who.int/document/aiq/5<br />

_8<strong>formaldehyde</strong>.pdf<br />

69. Health Canada, Residential Indoor Air To be supplemented<br />

Quality Guideline-Formaldehyde, 2006<br />

http://hc-sc.gc.calewh-selnt/alt<br />

forn1ats/hecssesc/pdf/pubs/air/<strong>formaldehyde</strong>-eng.pdf<br />

70. NIOSH, NIOSH Pocket Guide to<br />

Chemical Hazards, 2005<br />

http://www.cdc/gov/niosh/npg/npgd0293<br />

To be supplemented<br />

.html<br />

71. NIOSH, Method 2016 (Formaldehyde),<br />

Issue 2, NIOSH Manual of Analytical<br />

Methods (NMAM), Fourth Edition, 2003<br />

http://www.cdc.gov/Niosh/nmam/pdfs/2<br />

016.pdf<br />

72. ACGIH, Documentation of Threshold<br />

Limit Values and Biological Exposure<br />

Indices, 2001<br />

6<br />

LWFR-EXP 11-001662 –<br />

LWFR-EXP 11-001668<br />

LWFR-EXP11-000136 –<br />

LWFR-EXP11-000137<br />

73. Singh, Distribution of Selected Gaseous LWFR-EXP11-000138 -


Organic Mutagens and Suspect LWFR-EXP11-000146<br />

Carci<strong>no</strong>gens In Ambient Air<br />

74. ASHRAE – 62.2 Ventilation and<br />

Acceptable Indoor Air Quality in Low<br />

LWFR-EXP11-000147 –<br />

LWFR-EXP11-000222<br />

Rise Residential Buildings<br />

75. AHSRAE Standard 62.1 - 2004 LWFR-EXP11-000223 –<br />

LWFR-EXP11-000224<br />

76. ASTM – 1827 Blower Door LWFR-EXP11-000225 –<br />

LWFR-EXP11-000236<br />

77. ASTM E 1333 LWFR-EXP11-000237 –<br />

LWFR-EXP11-000248<br />

78. ATSDR 2007 Update Report LWRF-EXP11-000253 –<br />

LWFR-EXP11-000293<br />

79. ATSDR 2007 Report FEMA Temporary<br />

Housing Units<br />

LWFR-EXP 11-000772-<br />

LWFR-EXP 11-000785<br />

80. ATSDR Revised Report Baton Rouge LWFR-EXP 11-000786 –<br />

7<br />

LWFR-EXP 11-000826<br />

LWFR-EXP 11-000870 –<br />

LWFR-EXP 11-000883<br />

81. ATSDR Toxicological Profile for<br />

Formaldehyde<br />

82. CTEH Protocol LWFR-EXP 11-001032 –<br />

LWFR-EXP 11-001049<br />

83. Defendants’ Protocol LWFR-EXP 11-001050 –<br />

LWFR-EXP 11-001067<br />

84. Fact Sheet Early Findings LWFR-EXP 11-001193 –<br />

LWFR-EXP 11-001194<br />

85. FEMA Job Hazard Analysis Chart LWFR-EXP 11-001289<br />

86. HCOH in Houston Houses LWFR-EXP 11-001440 –<br />

LWFR-EXP 11-001444<br />

87. HCOH in LA CA Air - Grosjean LWFR-EXP 11-001445 –<br />

LWFR-EXP 11-001453<br />

88. HCOH in Mobil Homes LWFR-EXP 11-001454 –<br />

LWFR-EXP 11-001455<br />

89. HCOH in Urban Air LWFR-EXP 11-001456 –<br />

LWFR-EXP 11-001459<br />

90. Hodgson, VOCs in Indoor Air LWFR-EXP 11-001476 –<br />

LWFR-EXP 11-001506<br />

91. Litelpo, Inhaled HCOH LWFR-EXP 11-001507 –<br />

LWFR-EXP 11-001536<br />

92. LBNL-254E Final Report LWFR-EXP 11-001569 –<br />

LWFR-EXP 11-001629<br />

93. Lemus Study LWFR-EXP 11-001630 –<br />

LWFR-EXP 11-001639<br />

94. Long term Particleboard Emission<br />

Decay Study<br />

LWFR-EXP 11-001640 –<br />

LWFR-EXP 11-001643


95. Any and all Federal, State, Local, and<br />

Industry Regulations and Guidelines<br />

discussed and relied upon by any<br />

Defendant and/or Plaintiff experts in this<br />

matter.<br />

Articles<br />

96. July 20, 2007 “Formaldehyde and<br />

FEMA Trailers” by Lee Shull, Ph.D<br />

97. Maddalena, Randy; Russell, Marion;<br />

Sullivan, Douglas P.; an Apte, Michael<br />

G. “Aldehyde and Other volatile Organic<br />

Chemical Emissions in Four FEMA<br />

Temporary Housing Unites-Final<br />

Report”-Ernest Orlando Lawrence<br />

Berkeley National Laboratory,<br />

November 2008<br />

98. “Effect of Formaldehyde Inhalation on<br />

Hsp70 in Seminiferous Tubules of rat<br />

testes: an immu<strong>no</strong>histochemical study”<br />

by O. Ozen, et al. (2005)<br />

99. “Formaldehyde and Glutaradehyde and<br />

nasal Cytotoxicity: Case Study within<br />

the Context of the 2006 IPCS Human<br />

Framework for the Analysis of a Cancer<br />

Mode of Action for Humans” by D.<br />

McGregor, et al.<br />

100. “Effects of Inhaled Formaldehyde on<br />

Learning and Memory of Mice” by Z.<br />

Lu, et al. (2008)<br />

101. “Low Concentrations of Formaldehyde<br />

induce DNA damage and delay DNA<br />

repair after UV irradiation in Human<br />

Skin Cells” by G. Emri, et al. (2004)<br />

102. National Cancer Institute (NCI): Fact<br />

Sheet: Formaldehyde and Cancer Risk<br />

dated May 7, 2009<br />

103. National Cancer Institute (NCI):<br />

Formaldehyde Exposure among<br />

Industrial Workers is Associated with<br />

Increased Risk of Cancers of the Blood<br />

and Lymphatic System dated May 12,<br />

2009<br />

104. FEMA media release: FEMA Awards<br />

Contracts for Low Emissions Travel<br />

To be supplemented<br />

PSC021640 –<br />

PSC021641<br />

PSC025133 –<br />

PSC025193<br />

PSC021823 –<br />

PSC021829<br />

PSC021830 –<br />

PSC021846<br />

PSC021847 –<br />

PSC021854<br />

PSC021855 –<br />

PSC021866<br />

PSC021867 –<br />

PSC02<strong>1873</strong><br />

PSC026117 –<br />

PSC026118<br />

PSC021876 –<br />

PSC021879<br />

8


Trailers – April 7, 2009 – Release No.<br />

HQ-09-034b<br />

105. FEMA media release: FEMA to<br />

Introduce New Type of Manufactured<br />

Home – Dec. 18, 2008 – Release No.<br />

1791-343<br />

106. Article – “Formaldehyde Exposure in<br />

No<strong>no</strong>ccupational Environments” by K.<br />

Dally, et al.<br />

107. Article – “Formaldehyde-related Health<br />

Complaints of Residents Living in<br />

Mobile and Conventional Homes” by I.<br />

Ritchie, et al.<br />

108. Article – FEMA rolls out new disaster<br />

mobile homes: Formaldehyde levels are<br />

far below those of Hurricane Katrina,<br />

Rita <strong>trailer</strong>s dated 05/14/09<br />

109. Fact Sheet: Airborne Toxic Control<br />

Measure (ATCM) to Reduce<br />

Formaldehyde Emissions from<br />

Composite Wood Products<br />

110. Environmental Health – Formaldehyde<br />

Exposure in Homes: A Reference for<br />

State Officials to Use in Decision-<br />

Making (March 2008)<br />

111. Environmental Health – What you<br />

should k<strong>no</strong>w about Formaldehyde in<br />

Mobile Homes<br />

112. Formaldehyde Levels in FEMA-<br />

Supplied Trailers; Early Findings from<br />

the Centers for Disease Control and<br />

Prevention<br />

113. “Formaldehyde Indoors” by Dr. Stephen<br />

Smulski, April 1987, Progressive<br />

Builder, 12(4):9-11.<br />

114. Boyson, M. “Nasal mucosa in workers<br />

exposed to <strong>formaldehyde</strong>: a pilot study.”<br />

Br J of Ind Med 47:116-121, 1990<br />

115. Edling, C. “Occupational exposure to<br />

<strong>formaldehyde</strong> and histopathological<br />

changes in nasal mucosa.” Br J of Ind<br />

Med 45:761-765, 1988<br />

116. Holmstrom, M. “Histological Changes<br />

in the Nasal Mucosa in Rats after Long-<br />

PSC021880<br />

PSC021881 –<br />

PSC021888<br />

PSC021889 –<br />

PSC021894<br />

PSC021895 –<br />

PSC021896<br />

PSC026119 –<br />

PSC026120<br />

PSC021897 –<br />

PSC021902<br />

PSC021903 –<br />

PSC021906<br />

PSC003218 –<br />

PSC003219<br />

PSC002752 –<br />

PSC002754<br />

PSC002845 –<br />

PSC002853<br />

PSC002854 –<br />

PSC002865<br />

PSC002866 –<br />

PSC002881<br />

9


term Exposure to Formaldehyde and<br />

Wood Dust.” Acta Otolaryngol (Stockh)<br />

108:274-283, 1989<br />

117. Holmstrom, M. “Histological Changes<br />

in the Nasal Mucosa in Persons<br />

Occupationally Exposed to<br />

Formaldehyde Alone and in<br />

Combination with Wood Dust.” Acta<br />

Otolaryngol (Stockh) 107:120-129, 1989<br />

118. Garrett, MH. “Increased risk of allergy<br />

in children due to <strong>formaldehyde</strong><br />

exposure in homes.” Allergy 1999;<br />

54(4):330-7.<br />

119. Jaakkola, JJ. “Asthma, Wheezing, and<br />

Allergies in Russian Schoolchildren in<br />

Relation to New Surface Materials in the<br />

Home.” Am J Public Health<br />

2004;94(4):560-2<br />

120. Platts-Mills, TA. “Indoor allergens and<br />

asthma: Report of the Third<br />

International Workshop.” J Allergy Clin<br />

Immu<strong>no</strong>l 1997;100(6 Pt 1):S2-S24.<br />

121. “Legacy of Shame: The On-Going<br />

Public Health Disaster of Children<br />

Struggling in Post-Katrina Louisiana.”<br />

Children’s Health Fund & Columbia<br />

Univ. Mailman School of Public Health,<br />

Nov. 4, 2008<br />

122. “Children from FEMA <strong>trailer</strong> park battle<br />

serious health problems” <strong>US</strong>A Today<br />

11/24/08<br />

123. Wantke, F, “Exposure to gaseous<br />

<strong>formaldehyde</strong> induces IgE-mediated<br />

sensitization to <strong>formaldehyde</strong> in schoolchildren”<br />

Clinical and Experimental<br />

Allergy, 1996, Vol. 26, pages 276-280<br />

124. Krzyza<strong>no</strong>wski, Michal, “Chronic<br />

Respiratory Effects of Indoor<br />

Formaldehyde Exposure” Environmental<br />

Research 52, 117-125 (1990)<br />

125. “Indoor Residential Chemical Emissions<br />

as Risk Factor for Children’s<br />

Respiratory Health” by M. Mendell<br />

10<br />

PSC002882 –<br />

PSC002893<br />

PSC002898 –<br />

PSC002905<br />

PSC002906 –<br />

PSC002909<br />

PSC002909 –<br />

PSC002931<br />

PSC006033 –<br />

PSC006052<br />

PSC006053 –<br />

PSC006054<br />

PSC006055 –<br />

PSC006059<br />

PSC006060 –<br />

PSC006068<br />

PSC022228 –<br />

PSC022267<br />

126. “Formaldehyde and Leukemia: PSC026121 –


Epidemiology, Potential Mechanisms,<br />

and Implications for Risk Assessment”<br />

by Zhang, et al.<br />

127. “Formaldehyde-releasers: relationship to<br />

<strong>formaldehyde</strong> contact allergy. Contact<br />

allergy to <strong>formaldehyde</strong> and inventory of<br />

<strong>formaldehyde</strong>-releasers” by Groot, et al.<br />

128. “Prospective study of clinical symptoms<br />

and skin test reactions in medical<br />

students exposed to <strong>formaldehyde</strong> gas”<br />

by Takahashi, et al.<br />

129. “Influence of airborne nitrogen dioxide<br />

or <strong>formaldehyde</strong> on parameters of skin<br />

function and cellular activation in<br />

patients with atopic eczema and control<br />

subjects” by Eberlein-Konig, et al.<br />

130. Zinn, T.,D., Cline and W. Lehmann,<br />

Long Term Study of Formaldehyde<br />

Emission Decay from Particleboard,<br />

Forest Products Journal, June 1990.<br />

131. 2007 An Update and Revision of<br />

ATSDR’S February 2007 Health<br />

Consultation: Formaldehyde Sampling<br />

of FEMA Temporary-Housing Trailers<br />

Baton Rouge, Louisiana, September-<br />

October, 2006. U.S. Department of<br />

Health and Human Services Public<br />

Health Agency for Toxic Substances and<br />

Disease Registry. Atlanta Georgia.<br />

132. 2004. ANSI/HPVA Hp-1-2004<br />

American National Standard for<br />

Hardwood and Decorative Plywood.<br />

HPVA. Reston, Virginia.<br />

133. 1986. From Start to Finish<br />

Particleboard. National Particleboard<br />

Association. Gaithersburg, Maryland.<br />

134. 1986. From Start to Finish Medium<br />

Density Fiberboard. National<br />

Particleboard<br />

Association.<br />

Gaithersburg, Maryland.<br />

135. 2003. VOC Emission Barrier Effect of<br />

Laminates, Overlays and Coatings for<br />

Particleboard, Medium Density<br />

Fiberboard (MDF) and hardboard.<br />

PSC026131<br />

PSC026132 –<br />

PSC026154<br />

JAMES-008350<br />

JAMES-008356<br />

JAMES-008357<br />

JAMES-008359<br />

To be supplemented<br />

LWFR-EXP11-000253-<br />

LWFR-EXP11-000293<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

11


Composite Panel Association.<br />

Gaithersburg, Maryland.<br />

136. Barry, A. and D. Corneau. 2006.<br />

Effectiveness of barriers to minimize<br />

VOC emissions including <strong>formaldehyde</strong>.<br />

Forest Products Journal. 56(9):38-42<br />

137. Groah, W., G. Gramp and M. Trant.<br />

1984. Effect of a decorative vinyl<br />

overlay on <strong>formaldehyde</strong> emissions.<br />

Forest Products Journal 34(4):27-29.<br />

138. J. Thompson, et al., “Malingering” in<br />

Textbook of Forensic Psychiatry (2004),<br />

p. 427-449<br />

139. Seattle Times Op-Ed, June 6, 1980, A-7,<br />

“Formaldehyde Not Dangerous”<br />

140. Paustenbach, Dennis, Corporate<br />

Occupational Exposure Limits the<br />

Current State of Affairs, AIHA Journal,<br />

1986<br />

141. Atchison, J. and Brown, J., The<br />

Log<strong>no</strong>rmal Distribution, Cambridge<br />

University Press, 1957<br />

142. William H. Bullock, et al., A Strategy for<br />

Assessing and managing Occupational<br />

Exposures, AIHA (2006) (excerpts)<br />

143. Esman, et al, Log-Normality of<br />

Environmental Sampling Data, Journal<br />

of Environmental Science and Health<br />

(1977)<br />

144. Falk, Eric K., A Short Explanation of<br />

Retrospective Exposure Assessment and<br />

its Use in Toxic Tort Litigation, Toxic<br />

Torts and Environmental Law<br />

Committee Newsletter (Winter 2009)<br />

145. Gibbons and Coleman, Statistical<br />

Methods for Detection and<br />

Quantification of Environmental<br />

Contamination (2001)<br />

146. Glibert, Richard O., Statistical Methods<br />

for Environmental Pollution Monitoring<br />

(excerpts) (1987)<br />

147. Hewett, Paul, Mean Testing: II.<br />

Comparison of Several Alternative<br />

Procedures, Applied Occupational and<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

LWFR-GEN-000081<br />

LWFR-EXP3-000071-<br />

LWFR-EXP3-000080<br />

LWFR-EXP3-000081-<br />

LWFR-EXP3-000086<br />

LWFR-EXP3-000087-<br />

LWFR-EXP3-000099<br />

LWFR-EXP3-000100-<br />

LWFR-EXP3-000112<br />

LWFR-EXP3-000113-<br />

LWFR-EXP3-000114<br />

LWFR-EXP3-000115-<br />

LWFR-EXP3-000122<br />

LWFR-EXP3-000123-<br />

LWFR-EXP3-000129<br />

LWFR-EXP3-000130-<br />

LWFR-EXP3-000138<br />

12


Environmental Hygiene (1997)<br />

148. Hewett, Paul, “Chapter 16. Industrial<br />

Hygiene Exposure Assessment – Data<br />

Analysis and Interpretation”, from<br />

Handbook of Chemical Safety and<br />

Health (2001)<br />

149. Hodgson, et al., Volatile Organic<br />

compound Concentrations and Emission<br />

Rates in New Manufactured and Site-<br />

Built Homes, Indoor Air (2000)<br />

150. Land, C.E., Tables of Confidence Limits<br />

for Linear Functions of the Normal<br />

Mean and Variance, American<br />

Mathematical Society (1975)<br />

151. Nielsen, et al., Chemical and Biological<br />

Evaluation of Building Material<br />

Emissions, Indoor Air (1997)<br />

152. Paustenbach, Dennie, Occupational<br />

Exposure Limits, Pharmacokinetics, and<br />

Unusual Work Schedules (Chapter 7)<br />

(1994)<br />

153. Suta, Benjamin, Population Exposures<br />

to Atmospheric Formaldehyde Inside<br />

Residences, report to EPA (1980)<br />

154. Versar Final Report: “Formaldehyde<br />

Exposure Model – Description and<br />

Demonstration” (1986)<br />

155. Viet, et al., Guideline on Occupational<br />

Exposure Reconstruction, AIHA<br />

Guideline 11-2008<br />

156. White, et al., Principles of Exposure<br />

Measurement in Epidemiology,<br />

(excerpts) Oxford University Press<br />

(2008)<br />

157. Helena Ribeiro, Sugar Cane Burning in<br />

Brazil: Respiratory Health Effects, Rev.<br />

Saude Publica Vol. 42 <strong>no</strong>.2 Sao Paulo<br />

Apr. 2008 Epub February 29, 2008<br />

158. Lewis, Sax’s Dangerous Properties of<br />

Industrial Materials Tenth Edition and<br />

Hawley’s Condensed Chemical<br />

Dictionary Thirteenth Edition, Wiley,<br />

Hoboken, NJ, 2000.<br />

13<br />

LWFR-EXP3-000139-<br />

LWFR-EXP3-000169<br />

LWFR-EXP3-000217-<br />

LWFR-EXP3-000232<br />

LWFR-EXP3-000233-<br />

LWFR-EXP3-000239<br />

LWFR-EXP3-000241-<br />

LWFR-EXP3-000256<br />

LWFR-EXP3-000258-<br />

LWFR-EXP3-000259<br />

LWFR-EXP3-000260-<br />

LWFR-EXP3-000272<br />

LWFR-EXP3-000279-<br />

LWFR-EXP3000272<br />

LWFR-EXP3-000280-<br />

LWFR-EXP3-000285<br />

LWFR-EXP3-000286-<br />

LWFR-EXP3-000290<br />

LWFR-EXP7-009919-<br />

LWFR-EXP7-009926<br />

To be supplemented<br />

159. California EPA, ARB, Indoor Air To be supplemented


Quality Guideline-Formaldehyde in the<br />

Home, 2004<br />

http://www.arb.ca.gov/researchiindoor/f<br />

ormaldg108-04.pdf<br />

160. Formaldehyde Sampling: Active and<br />

Passive Sampling Protocols, DeVany,<br />

2008<br />

161. AIHA, AIHA Field Guide for<br />

Determination of Biological<br />

Contaminants , Second Edition, 2005<br />

162. Casset A, Purohit A, Marchand C, et al.:<br />

“The Bronchial response to inhaled<br />

<strong>formaldehyde</strong>”<br />

163. Dingle P; “Formaldehyde in Occupied<br />

and U<strong>no</strong>ccupied Caravans in Australia”<br />

164. Songul Acar Vaizoglu; “Determining<br />

Domestic Formaldehyde Levels in<br />

Ankara, Turkey”<br />

165. Fenna A Ebbens, MD, MSc; “The Mold<br />

Conundrum in Chronic Rhi<strong>no</strong>sinusitis:<br />

Where Do We Stand Today?”<br />

166. American College of Occupational and<br />

Environmental Medicine “Adverse<br />

Human Health Effects Associated with<br />

Molds in the Indoor Environment”<br />

167. Affidavit of Patricia M. Williams, PH.D.<br />

D.A..B.T. in the Trial of Alana<br />

Alexander And Christopher Cooper<br />

168. Allenby CF, Basketter DA; “The effect<br />

of repeated open exposure to low levels<br />

of nickel on compromised hand skin of<br />

nickel-allergic subjects”<br />

14<br />

To be supplemented<br />

To be supplemented<br />

LWFR-EXP15-000131-<br />

LWFR-EXP15-000141<br />

LWFR-EXP15-000142-<br />

LWFR-EXP15-000147<br />

LWFR-EXP15-000148-<br />

LWFR-EXP15-000155<br />

LWFR-EXP15-000156-<br />

LWFR-EXP15-000164<br />

LWFR-EXP15-000209-<br />

LWFR-EXP15-000222<br />

LWFR-EXP15-000223-<br />

LWFR-EXP15-000264<br />

LWFR-EXP15-000165-<br />

LWFR-EXP15-000169<br />

169. Allergen Patch Test-Information of<br />

Patients<br />

LWFR-EXP15-000265-<br />

LWFR-EXP15-000303<br />

170. Allergen Patch Test-TRUE test LWFR-EXP15-000304-<br />

LWFR-EXP15-000345<br />

171. D. Sciandra, F. Dispenza, R. Porcasi. G.<br />

Kulamarva, C. Saraniti,<br />

Otorhi<strong>no</strong>laryngology Department;<br />

Human Pathology Department,<br />

University of Palermo, Italy; ENT<br />

Clinic, Nayak’s Road, Kasaragod, India<br />

“Pleomorphic ade<strong>no</strong>ma of the lateral<br />

nasal wall: case report”<br />

LWFR-EXP15-000170-<br />

LWFR-EXP15-000173


172. Josje H. E. Arts, Carolien Mommers,<br />

and Cees de Heer “Dose-Response<br />

Relationships and Threshold Levels in<br />

Skin and Respiratory Allergy”<br />

173. Ralph J Delfi<strong>no</strong>, Henry Gong, Jr.,<br />

William S. Linn, Edo D. Pellizzari, and<br />

Ye Hu “Asthma Symptoms in Hispanic<br />

Children and Daily Ambient Exposures<br />

to Toxic and Criteria Air Pollutants”<br />

15<br />

LWFR-EXP15-000174-<br />

LWFR-EXP15-000208<br />

LWFR-EXP15-000346-<br />

LWFR-EXP15-000356<br />

174. Author Reply; Comment LWFR-EXP15-000357-<br />

LWFR-EXP15-000359<br />

175. M.A. Anderson, M. Nikulin, U. Koljalg,<br />

M. Anderson, F. Rainey, K. Reijula, E. –<br />

L Hintikka, and M. Salki<strong>no</strong>ja-Salonen<br />

“Bacteria, Molds, and Toxins in Water-<br />

Damaged Building Materials”<br />

LWFR-EXP15-000360-<br />

LWFR-EXP15-000366<br />

176. Bender, J; “The use of <strong>no</strong>ncancer<br />

endpoints as a basis for establishing a<br />

reference concentration for<br />

<strong>formaldehyde</strong>”<br />

178. Hodgson, Michael J. Md, MPH; Morey,<br />

Philip, PhD; Leung, Wing-Yan, BS;<br />

Morrow, Lisa PhD; Miller, David, PhD;<br />

Jarvis, Bruce, PhD; Robbins, Howard,<br />

MD;<br />

Halsey, John F. PhD; Storey, Eileen,<br />

MD, MPH; “Building-Associated<br />

Pulmonary Disease from Exposure to<br />

Stachbotrys chartarum and Apsergillus<br />

versicolor”<br />

179. Stuart M. Brooks, Wil Spaul and James<br />

D. McCluskey “The Spectrum of<br />

Building-Related Airway Disorders”<br />

180. J.H Olsen, L. Dragstead & H. Autrup<br />

“Cancer Risk and occupational exposure<br />

to aflatoxins in Denmark”<br />

181. CDC Update “Pulmonary<br />

Hemorrhage/Hemosiderosis among<br />

Infants—Cleveland, Ohio, 1993-1996”<br />

January 17, 1997/46 (02); 33-35<br />

LWFR-EXP15-000367-<br />

LWFR-EXP15-000376<br />

177. Bissett, Drobatz, McKnight, Degernes;<br />

“Prevalence, clinical features, and causes<br />

of epistaxes in dogs”; 176 cases (1996-<br />

2001)<br />

LWFR-EXP15-000377-<br />

LWFR-EXP15-000385<br />

LWFR-EXP15-000386-<br />

LWFR-EXP15-000395<br />

LWFR-EXP15-000396-<br />

LWFR-EXP15-000405<br />

LWFR-EXP15-000406-<br />

LWFR-EXP15-000409<br />

LWFR-EXP15-000410-<br />

LWFR-EXP15-000412


182. CDC Update “Pulmonary<br />

Hemorrhage/Hemosiderosis among<br />

Infants—Cleveland, Ohio, 1993-1996”<br />

March 10, 2000-49 (09); 180-4<br />

183. Chalyasate, Roongrotwattansairi,<br />

Fooanan, Sumitsawan; “Epistaxis in<br />

Chiang Mai University Hospital”<br />

184. Chang “Contact Dermatitis<br />

1997:37:309”<br />

LWFR-EXP15-000413-<br />

LWFR-EXP15-000421<br />

LWFR-EXP15-000422-<br />

LWFR-EXP15-000427<br />

LWFR-EXP15-000428-<br />

LWFR-EXP15-000431<br />

185. Clement PA, Stoot AP, Kaufman L; the<br />

“Influence of <strong>formaldehyde</strong> on the nasal<br />

mucosa”<br />

186. Clinical and Pathogenic Microbiology<br />

(Second Edition)<br />

187. Pierre Auger, MD, Pierre Gourdeau,<br />

MD, and J. David Miller, PhD “Clinical<br />

Experience with Patients Suffering from<br />

a Chronic Fatigue-Like Syndrome and<br />

Repeated Upper Respiratory Infections<br />

in Relation to Airborne Molds”<br />

188. Torkel Fischer, Klaus Anderson, Ulla<br />

Bengtsson, Peter Frosch, Yen<br />

Gunnarssan, Bo Kreilgard, Torkil<br />

Menne, Stephanie Shaw, Louise<br />

Svennson, John Wilkinson “Clinical<br />

Standardization of the TRUE Test<br />

Formaldehyde Patch”<br />

189. Clinical Toxicology-Stachybotrys<br />

Revisited<br />

190. Douglas H. Linz, MD, MS; Susan M.<br />

Pinney, PhD; James D. Keller, MD, MS;<br />

Michael White, MS; C. Ralph Buncher,<br />

ScD; “Cluster Analysis Applied to<br />

Building-Related Illness”<br />

191. Code of Federal Regulations-29-Part<br />

1910-July 1990<br />

192. Luis M. de la Maza, M.D., Ph.D., Marie<br />

T. Pezzlo, M.A (AAM); Ellen Jo Baron.,<br />

F (AAM) “Color Atlas of Diag<strong>no</strong>stic<br />

Microbiology”<br />

193. Comment, Comment ILL Number:<br />

55546440<br />

16<br />

LWFR-EXP15-000432-<br />

LWFR-EXP15-000438<br />

LWFR-EXP15-000439-<br />

LWFR-EXP15-000440<br />

LWFR-EXP15-000441-<br />

LWFR-EXP15-000442<br />

LWFR-EXP15-000443-<br />

LWFR-EXP15-000449<br />

LWFR-EXP15-000450-<br />

LWFR-EXP15-000452<br />

LWFR-EXP15-000453-<br />

LWFR-EXP15-000459<br />

LWFR-EXP15-000460-<br />

LWFR-EXP15-000461<br />

LWFR-EXP15-000462-<br />

LWFR-EXP15-000463<br />

LWFR-EXP15-000464-<br />

LWFR-EXP15-000466<br />

194. P. Sherwood Burge, A.S Robertson, and LWFR-EXP15-000467-


A.Hedge “Comparison of Self-<br />

Administered Questionnaire with<br />

Physician Diag<strong>no</strong>sis in the Diag<strong>no</strong>sis of<br />

the Sick Building Syndrome”<br />

195. J.M Fernandez Vozmedia<strong>no</strong> and J.C<br />

Armario Hita “Concordance and<br />

discordance between TRUE Test and<br />

Finn Chamber”<br />

196. S. Iris Ale and Howard I. Maibach<br />

“Reproducibility of patch test results: a<br />

concurrent right-versus-left study using<br />

TRUE Test”<br />

197. Daele, Vander, Poorten, Rombaux,<br />

Hamoir; “Cancer of the nasal vestibule,<br />

nasal cavity and paranasal sinuses”<br />

198. Robert Dales MD MSc(Epid), Ling Liu<br />

MMD PhD, Amanda J. Wheeler PhD,<br />

Nicolas L. Gilbert MSc “Quality of<br />

indoor residential air and health”<br />

199. B. Brunekreef “Damp housing and adult<br />

respiratory symptoms”<br />

200. Chih-Shan Li, Ching-Wan HSU, Chia-<br />

Hui Lu “Dampness and Respiratory<br />

Symptoms among workers in Daycare<br />

Centers in a Subtropical Climate”<br />

201. T.L Brasel, D.R Douglas, S.C Wilson,<br />

and D.C Straus “Detection of Airborne<br />

Stachybotrys chartarum Macrocyclic<br />

Trichothecene Mycotoxins on<br />

Particulates Smaller than Conidia”<br />

202. Louise Arup Fischer, Torkil Menne, and<br />

Jeanne Duus Johansen “Dose per unit<br />

area-a study of elicitation of nickel<br />

allergy”<br />

203. Druce HM; “Nasal provocation<br />

challenge-strategies for experimental<br />

design”<br />

204. Paul Ar<strong>no</strong>w, M.D; Jordan Fink, M.D.;<br />

Donald Schleuter, M.D.; Joseph<br />

Barboriak, Sc.D.;<br />

George Mallison, M.P.H; Sami Said,<br />

M.D; Stanley Martin, M.S.; George<br />

Unger, M.D; Gerald Scanlon, M.D;<br />

Viswanath Kurup, Ph.D.; “Early<br />

LWFR-EXP15-000470<br />

LWFR-EXP15-000471-<br />

LWFR-EXP15-000472<br />

LWFR-EXP15-000473-<br />

LWFR-EXP15-000482<br />

LWFR-EXP15-000483-<br />

LWFR-EXP15-000493<br />

LWFR-EXP15-000494-<br />

LWFR-EXP15-000499<br />

LWFR-EXP15-000500-<br />

LWFR-EXP15-000504<br />

LWFR-EXP15-000505-<br />

LWFR-EXP15-000508<br />

LWFR-EXP15-000509-<br />

LWFR-EXP15-000517<br />

LWFR-EXP15-000523-<br />

LWFR-EXP15-000529<br />

LWFR-EXP15-000530-<br />

LWFR-EXP15-000536<br />

LWFR-EXP15-000537-<br />

LWFR-EXP15-000543<br />

17


Detection of Hypersensitivity<br />

Pneumonitis in Office Workers”<br />

205. Fenna A Ebbens, Christos Georgalas and<br />

Wytske J. Fokkens “Fungus as the cause<br />

of chronic rhi<strong>no</strong>sinusitis: the case<br />

remains unproven”<br />

206. Fenna A Ebbens, MD, MSc, and Wytske<br />

J. Fokkens, MD, PhD “The Mold<br />

Conundrum in Chronic Rho<strong>no</strong>sinusitis:<br />

Where Do We Stand Today?”<br />

207. Mario Nikulin, Kari Reijula, Bruce<br />

Jarvis, Pirio Veijalanien and Eeva-Liisa<br />

Hintikka<br />

“Effects of Intranasal Exp to Spores of<br />

Stachybotrys Atria in Mice”<br />

208. Noreen N. Khan and Bobby Wilson<br />

“Environmental Assessment of Mold<br />

Concentrations and Potential Mycotoxin<br />

in the Greater Southeast Texas Area”<br />

209. U.S Environmental Protection Agency<br />

“EPA Fine Particle PM 2.5<br />

Designations”<br />

18<br />

LWFR-EXP15-000544-<br />

LWFR-EXP15-000550<br />

LWFR-EXP15-000551-<br />

LWFR-EXP15-000559<br />

LWFR-EXP15-000560-<br />

LWFR-EXP15-000566<br />

LWFR-EXP15-000567-<br />

LWFR-EXP15-000581<br />

LWFR-EXP15-000582-<br />

LWFR-EXP15-000604<br />

210. EPA Safe Contaminent Chart LWFR-EXP15-000605-<br />

LWFR-EXP15-000610<br />

211. M. Lei<strong>no</strong>, M. Makela, K. Reijula, T.<br />

Haahtlat, H. Mussalo-Rauhamaa, T.<br />

Toumi, E-L Hintikka, and H. Alenius<br />

“Intranasal exposure to a damp building<br />

mould, Stachybotrys chartarum, induces<br />

lung inflammation in mice by satraxinindependent<br />

mechanisms”<br />

LWFR-EXP15-000611-<br />

LWFR-EXP15-000618<br />

212. Claus Zachariae, Barbara Hall, Martine<br />

Cottin, Sylve Cupferman, Klaus<br />

Andersen, T. Menne “Experimental<br />

elicitation of contact allergy from a<br />

diazolidinyl uera-preserved cream in<br />

relation to anatomical region, exposure<br />

time and concentration”<br />

213. Marjo Nikulin, Kari Reijula, Bruce B<br />

Jarvis, and Eeva-Liisa Hintikka<br />

“Experimental Lung Mycotoxicosis in<br />

Mice Induced by Stachybotrys Atra”<br />

214. L.A. Fischer, J.D Johnson, and T. Menne<br />

“Methyldibromoglutaronitrile allergy:<br />

LWFR-EXP15-000619-<br />

LWFR-EXP15-000629<br />

LWFR-EXP15-000630-<br />

LWFR-EXP15-000634<br />

LWFR-EXP15-000635-<br />

LWFR-EXP15-000641


elationship between patch test and<br />

repeated open application test<br />

thresholds”<br />

215. Lawrence Fishbein, PhD “Exposure<br />

from occupational versus other sources”<br />

216. Floods Carry Potential for Toxic Mold<br />

Disease; May 1997<br />

217. Flyvholm MA, Hall BM, et al;<br />

Threshold for occluded <strong>formaldehyde</strong><br />

patch test in <strong>formaldehyde</strong>-sensitive<br />

patients. Relationship to repeated open<br />

applica”<br />

218. Peter Franklin, Peter Dingle, and<br />

Stephen Stick “Raised Exhaled Nitric<br />

Oxide in Healthy Children is Associated<br />

with Domestic Formaldehyde Levels”<br />

219. Karl E. Frees, et al “Severe complication<br />

after administration if formalin for<br />

treatment of progressive ethomidal<br />

hematoma in a horse”.<br />

220. Kazuyasu Fujii, et al “Effect of<br />

<strong>formaldehyde</strong> Gas Exposure in a Marine<br />

Allergic Contact Hypersensitivity<br />

Model”<br />

221. Fran Fisher., M.T. (ASCP), et al<br />

“Fundamentals of Diag<strong>no</strong>stic<br />

Mycology”<br />

19<br />

LWFR-EXP15-000642-<br />

LWFR-EXP15-000654<br />

LWFR-EXP15-000655-<br />

LWFR-EXP15-000656<br />

LWFR-EXP15-000657-<br />

LWFR-EXP15-000665<br />

LWFR-EXP15-000666-<br />

LWFR-EXP15-000668<br />

LWFR-EXP15-000669-<br />

LWFR-EXP15-000670<br />

LWFR-EXP15-000671-<br />

LWFR-EXP15-000684<br />

LWFR-EXP15-000685-<br />

LWFR-EXP15-000686<br />

222. James Gibson “Formaldehyde Toxicity” LWFR-EXP15-002177-<br />

LWFR-EXP15-002178<br />

223. Gollhausen Rainer, et al<br />

“Reproducibility of patch test results;<br />

Comparison of TRUE Test and Finn<br />

Chamber Test Results”<br />

LWFR-EXP15-000687-<br />

LWFR-EXP15-000691<br />

224. Gottschalk C, Bauer J, Meyer K.;<br />

“Detection of Satratoxin G and H Indoor<br />

Air from a Water-Damaged Building”<br />

225. Gutarowska B, Wiszniewska M, et al;<br />

“Exposure to moulds in flats and the<br />

prevalence of allergic diseasespreliminary<br />

study”<br />

LWFR-EXP15-000692-<br />

LWFR-EXP15-000697<br />

LWFR-EXP15-000698-<br />

LWFR-EXP15-000706<br />

226. Unk<strong>no</strong>wn, Erratum LWFR-EXP15-000707-<br />

LWFR-EXP15-000708<br />

227. R.W Hanckel, M.D., and Richard Carter,<br />

M.D.; “Epistaxis”<br />

LWFR-EXP15-000709-<br />

LWFR-EXP15-000714


228. Haraguchi, Ebihara, Saikawa, et al;<br />

“Malignant tumors of the nasal cavity;<br />

review of a 60-case series”<br />

229. Hata, H, Taka<strong>no</strong> H, Matsumiya G., et al;<br />

“Late complications of gelatin-resorcinformalin<br />

glue in the repair of acute type<br />

A aortic dissection”<br />

230. Jun-ichi Hattori, MD, et al;<br />

“Bronchospasm Induced by Propofol in<br />

a Patient with Sick House Syndrome”<br />

20<br />

LWFR-EXP15-000715-<br />

LWFR-EXP15-000723<br />

LWFR-EXP15-000724-<br />

LWFR-EXP15-000731<br />

LWFR-EXP15-000732-<br />

LWFR-EXP15-000733<br />

231. Hazard Communication LWFR-EXP15-000734-<br />

LWFR-EXP15-000756<br />

232. Eckardt Johanning, et al; “Health and<br />

Immu<strong>no</strong>logy study following exposure<br />

to toxigenic fungi (Stachybotrys<br />

chartarum) in a water damaged office<br />

environment”<br />

LWFR-EXP15-000757-<br />

LWFR-EXP15-000768<br />

233. Peter Kozak Jr.; “Home Mold Surveys” LWFR-EXP15-000769-<br />

LWFR-EXP15-000778<br />

234. IARC Vol 100 F- A review of human LWFR-EXP 15-000779<br />

carci<strong>no</strong>gens Part F<br />

235. Imidazolidinyl Urea 39236-46-9 LWFR-EXP15-000780-<br />

LWFR-EXP15-000797<br />

236. Immu<strong>no</strong>logy 7th Edition -<br />

Hypersensitivity Type IV - Chapter 26<br />

LWFR-EXP15-000798-<br />

LWFR-EXP15-000800<br />

237. Dales, Robert, et al; “ndoor Air Quality<br />

and Health; Reproducibility of<br />

Respiratory Symptoms and Reported<br />

Home Dampness and Molds using a<br />

Self-Administered Questionnaire”<br />

LWFR-EXP15-000801-<br />

LWFR-EXP15-000806<br />

238. D.M Kuhn and M.A Ghan<strong>no</strong>um “Indoor<br />

Mold, Toxigenic Fungi, and<br />

Stachybotrys Charatarum: Infectious<br />

Disease Perspective”<br />

239. Ana Rask-Anderson, et al; “Inhalation<br />

Fever and Respiratory Symptoms in<br />

Swedish Sawmills”<br />

240. Izulani H. Shibukawa, et al; Devasting<br />

late complication for repair of type A<br />

Acute aortic dissection with usage of<br />

gelatin-resorci<strong>no</strong>l-formalin glue”<br />

241. C. Janson, et al; “European Community<br />

Respiratory Health Survey: What are the<br />

main results so far?”<br />

LWFR-EXP15-000807-<br />

LWFR-EXP15-000835<br />

LWFR-EXP15-000836-<br />

LWFR-EXP15-000838<br />

LWFR-EXP15-000839-<br />

LWFR-EXP15-000844<br />

LWFR-EXP15-000845-<br />

LWFR-EXP15-000858


242. Jerzy Kaminski, et al; “Determination of<br />

Formaldehyde in Fresh and Retail Milk<br />

by Liquid Colmn Chromatography”<br />

243. Teruhisa Kazui, MD, et al; “Role of<br />

Biologic Glue Repair of Proximal Aortic<br />

Dissection in the Development of Early<br />

and Midterm Redissection of the Aortic<br />

Root”<br />

244. Edward Kerfoot, PhD., et al;<br />

“Formaldehyde and Para<strong>formaldehyde</strong><br />

Study in Funeral Homes”<br />

245. Matthias Kirsch, MD., et al; “Aortic<br />

Alterations After Use of Gelatin-<br />

Resorci<strong>no</strong>l-Formalin Glue”<br />

246 Jame Koenig, PhD.; “Indoor and outdoor<br />

pollutants and the upper respiratory<br />

tract”<br />

247 Henrik Kolstad “Do Indoor Molds in<br />

Non-Industrial Environments Threaten<br />

Workers’ Health? A Review of the<br />

Epidemiologic Evidence”<br />

248 Koltai PJ “Effects of air pollution on the<br />

upper respiratory tract of children”<br />

21<br />

LWFR-EXP15-000859-<br />

LWFR-EXP15-000860<br />

LWFR-EXP15-000861-<br />

LWFR-EXP15-000866<br />

LWFR-EXP15-000867-<br />

LWFR-EXP15-000869<br />

LWFR-EXP15-000870-<br />

LWFR-EXP15-000873<br />

LWFR-EXP15-000874-<br />

LWFR-EXP15-000876<br />

LWFR-EXP15-000877-<br />

LWFR-EXP15-000891<br />

LWFR-EXP15-000892-<br />

LWFR-EXP15-000895<br />

249 Lab Rpt Badge 8-06-09 LWFR-EXP15-000896<br />

250 Lab Rpt Tube 8-06-09 LWFR-EXP15-000897<br />

251 Lee Ch, Maibach HI; “Study of<br />

cumulative irritant contact dermatitis in<br />

man utilizing open application on sub<br />

clinically irritated skin”<br />

LWFR-EXP15-000898-<br />

LWFR-EXP15-000903<br />

252 PR Morey PhD “Microbiological<br />

Contamination in Buildings”<br />

LWFR-EXP15-000904-<br />

LWFR-EXP15-000910<br />

253 Suzanne Gravesen “Microfungal<br />

Contamination of Damp Buildings”<br />

LWFR-EXP15-000911-<br />

LWFR-EXP15-000914<br />

254 Mold Culture Lab Rpt 8-29-09 LWFR-EXP15-000915-<br />

LWFR-EXP15-000918<br />

255 Michael C.R Alvanja “Mortality Study<br />

of Workers in Grain Industry”<br />

LWFR-EXP15-000919-<br />

LWFR-EXP15-000924<br />

256 MSDS Sheet Formaldehyde LWFR-EXP15-000925-<br />

LWFR-EXP15-000936<br />

257 Mycotoxins - Ruth A Etzel MD LWFR-EXP15-000937-<br />

LWFR-EXP15-000939<br />

258 Mycotoxins & Public Health - Malloy LWFR-EXP15-000940-<br />

CD Marr JS<br />

LWFR-EXP15-000949<br />

259 Tapani Tuomi “Mycotoxins in Crude LWFR-EXP15-000950-


Bldg Materials from Water Damaged<br />

Bldgs”<br />

260 NIOSH Criteria for a Recommended<br />

Standard - Occupational Exposure<br />

261 Sheila West “Non Viral Risk Factors for<br />

Nasopharyngeal Carci<strong>no</strong>ma in The<br />

Philippines”<br />

262 Norback, D, et al; “Asthmatic symptoms<br />

and violatile organic compounds,<br />

<strong>formaldehyde</strong> and carbon dioxide in<br />

dwellings”<br />

263 Ogunleye, et al; “Usual and unusual<br />

features of si<strong>no</strong>nasal cancer in Nigerian<br />

Africans; a prospective study of 27<br />

patients”<br />

264 Formaldehyde 2016, NIOSH Manual of<br />

Analytical Methods, Fourth Edition<br />

265 Formaldehyde by Vis 3500, NIOSH<br />

Manual of Analytical Methods, Fourth<br />

Edition<br />

266 OSHA Formaldehyde Sampling<br />

Method, Method Development Team,<br />

Industrial Hygiene Chemistry Division<br />

267 OSHA Formaldehyde Sampling Method<br />

1007, Method Development Team,<br />

Industrial Hygiene Chemistry Division<br />

268 X Weng, CH Chon, H Jiang, D Li,<br />

“Rapid Detection of Formaldehyde<br />

Concentration in Food on a<br />

Polydimethylsiloxane (PDMS)<br />

Microfluidic Chip” Food Chemistry 114<br />

(2009) 1079-1082.<br />

269 Evaluation of Formaldehyde Levels in<br />

Occupied Federal Emergency<br />

Management Agency-Owned Temporary<br />

Housing Units, National Center for<br />

Environmental Health.<br />

270 Franklin Mirer, “Risky Business:<br />

Forming Your Opinion of Katrina, Part<br />

1” The Synergist, January 2009<br />

271 LJ Salas and HB Singh, “Measurements<br />

of Formaldehyde and Acetaldehyde in<br />

the Urban Ambient Air” Atmospheric<br />

Environment Vol. 20 No. 6. (1986) pp.<br />

LWFR-EXP15-000955<br />

LWFR-EXP15-000956-<br />

LWFR-EXP15-000958<br />

LWFR-EXP15-000959-<br />

LWFR-EXP15-000965<br />

LWFR-EXP15-000966-<br />

LWFR-EXP15-000974<br />

LWFR-EXP15-000975-<br />

LWFR-EXP15-000981<br />

LWFR-EXP11-001662-<br />

LWFR-EXP11-001668<br />

LWFR-EXP11-001669-<br />

LWFR-EXP11-001673<br />

LWFR-EXP11-001691-<br />

LWFR-EXP11-001726<br />

LWFR-EXP11-001727-<br />

LWFR-EXP11-001758<br />

LWFR-EXP11-001962-<br />

LWFR-EXP11-001965.<br />

LWFR-EXP11-001926-<br />

LWFR-EXP11-001961<br />

LWFR-EXP11-001966-<br />

LWFR-EXP11-001969<br />

LWFR-EXP11-002128-<br />

LWFR-EXP11-002131<br />

22


1301-1304.<br />

272 OSHA Summary of Air and Noise<br />

Sampling Results Representing Actual<br />

or Potential Exposures for Response and<br />

Recovery Workers Involved in<br />

Hurricane Response and Recovery<br />

Activities<br />

273 DeVanny Industrial Consultants,<br />

Formaldehyde Sampling: Active and<br />

Passive Sampling Protocols March 2008<br />

274 Ohmichi, Kimihide “Formaldehyde<br />

Exposure in a Gross Anatomy<br />

Laboratory”<br />

275 Jonathan White “Oral Tolerance to<br />

Contact Allergens”<br />

276 Osguthorpe, David “Frontal Sinus<br />

Malignancies”<br />

23<br />

LWFR-EXP11-001759-<br />

LWFR-EXP11-001761<br />

LWFR-EXP11-001762-<br />

LWFR-EXP11-001890<br />

LWFR-EXP15-000982-<br />

LWFR-EXP15-000987<br />

LWFR-EXP15-000988-<br />

LWFR-EXP15-000996<br />

LWFR-EXP15-000997-<br />

LWFR-EXP15-001010<br />

277 OSHA Recognized Carci<strong>no</strong>gens LWFR-EXP15-001011-<br />

LWFR-EXP15-001012<br />

278 Michael Hodgson “Outbreak Recurrent LWFR-EXP15-001013-<br />

Chronic Hypersensitivity Pneumonitis LWFR-EXP15-001020<br />

office workers”<br />

279 B.A Owen, et al;” Formaldehyde in<br />

Drinking Water: Comparative Hazard<br />

Evaluation and an Approach to<br />

Regulation”<br />

280 Elizabeth Sherertz “Patch Testing<br />

Discordance Alert - False Negative<br />

Findings”<br />

281 Pattys Toxicology 5th Edition Volume 5<br />

- Aldehydes and Acetals<br />

282 Paustenbach, et al; “A recommended<br />

occupational exposure limit for<br />

<strong>formaldehyde</strong> based on irritation”<br />

283 Pediatrics- Toxic Effects of Indoor<br />

Molds March 2005<br />

284 Christina Scheel, et al; “Possible Sources<br />

of Sick Bldg Syndrome Tennesee<br />

Middle School”<br />

285 Paivi Rauni, et al; “Preliminary<br />

Description of Antigenic Components<br />

Characteristic”<br />

286 Michael Hodgson, et al; “Pulmonary<br />

Disease Associated with Cafeteria<br />

LWFR-EXP15-001021-<br />

LWFR-EXP15-001038<br />

LWFR-EXP15-00139-<br />

LWFR-EXP15-001040<br />

LWFR-EXP15-001041-<br />

LWFR-EXP15-001042<br />

LWFR-EXP15-001043-<br />

LWFR-EXP15-001090<br />

LWFR-EXP15-001091-<br />

LWFR-EXP15-001095<br />

LWFR-EXP15-000196-<br />

LWFR-EXP15-001100<br />

LWFR-EXP15-001101-<br />

LWFR-EXP15-001110<br />

LWFR-EXP15-001111-<br />

LWFR-EXP15-001116


Flooding”<br />

287 Tove Agner – “Formaldehye Allergy –<br />

A Follow Up Study”<br />

288 Arts – “Inhaled formaledhydeevaluation<br />

of sensory irritation in<br />

relation to carci<strong>no</strong>genicity”<br />

289 Arts – “Setting an indoor air exposure<br />

limit for <strong>formaldehyde</strong>_ Factors of<br />

concern”<br />

290 Ballarin, Cinzia – “Micronucleated Cells<br />

in Nasal Mucosa”<br />

291 Ballenger, MD, John J.– “Some Effects<br />

of Formaldehyde on the Upper<br />

Respiratory Tract”<br />

292 Barreto, Mauricio L. – “Risk Factors and<br />

Immu<strong>no</strong>logical Pathways for Asthma<br />

and Other Allergic Diseases in Children”<br />

293 Batra, Jyotsna – “Inductible Nitric Oxide<br />

Synthase”<br />

294 Berke, MD, Jerry H. – “Cytologic<br />

Examination of the Nasal Mucosa in<br />

Formaldehyde-exposed Workers”<br />

295 Bermudez – “Characterization of Cell<br />

Lines Derived from Formaldehyde-<br />

Induced Nasal Tumors in Rats”<br />

296 Blair – “Epidemiologic Evidence on the<br />

relationship between <strong>formaldehyde</strong><br />

exposure and cancer”<br />

297 Bolt – “Experimental Toxicology of<br />

Formaldehyde”<br />

298 Boysen – “Nasal Mucosa of Workers<br />

Exposed to HCHO”<br />

299 Bredt -“Endoge<strong>no</strong>us Nitric Oxide<br />

Synthesis”<br />

300 Brown, Sara J. – “Atopic Eczema and<br />

the Filaggrin Story”<br />

301 Bruynzeel – “Formaldehyde Contact<br />

Sensitivity and the use of Shampoo”<br />

302 Burgaz – “Micronuclei Frequencies in<br />

Exfoliated Nasal Mucosa Cells from<br />

Pathology and Anatomy Laboratory<br />

Workers”<br />

303 Casa<strong>no</strong>va – “Covalent Binding of<br />

Inhaled<br />

LWFR-EXP15-002179-<br />

LWFR-EXP15-002184<br />

LWFR-EXP15-002185-<br />

LWFR-EXP15-002201<br />

LWFR-EXP15-002202-<br />

LWFR-EXP15-002207<br />

LWFR-EXP15-002208-<br />

LWFR-EXP15-002214<br />

LWFR-EXP15-002215-<br />

LWFR-EXP15-002218<br />

LWFR-EXP15-002219-<br />

LWFR-EXP15-002228<br />

LWFR-EXP15-002229-<br />

LWFR-EXP15-002237<br />

LWFR-EXP15-002238-<br />

LWFR-EXP15-002242<br />

LWFR-EXP15-002243-<br />

LWFR-EXP15-002250<br />

LWFR-EXP15-002251-<br />

LWFR-EXP-002266<br />

LWFR-EXP15-000267-<br />

LWFR-EXP15-002272<br />

LWFR-EXP15-002273<br />

LWFR-EXP15-002279<br />

LWFR-EXP15-000280–<br />

LWFR-EXP15-002302<br />

LWFR-EXP15-002303-<br />

LWFR-EXP15-002313<br />

LWFR-EXP15-002314-<br />

LWFR-EXP15-002316<br />

LWFR-EXP15-002317-<br />

LWFR-EXP15-002321<br />

LWFR-EXP15-002322-<br />

LWFR-EXP15-002343<br />

24


Formaldehyde to DNA in the<br />

Respiratory<br />

Tract of Rhesus Monkeys”<br />

304 Casa<strong>no</strong>va – “DNA-Protein Cross-Links<br />

and Cell Replication at Specific Sites in<br />

the Nose of F344 Rats”<br />

305 Casarett & Doull's – Toxicology – “The<br />

Basic Science of Poisons” – Sixth<br />

Edition<br />

306 Casset – “Le Formaldehyde inhale et la<br />

response bronchique”<br />

25<br />

LWFR-EXP15-002344-<br />

LWFR-EXP15-002356<br />

LWFR-EXP15-002357-<br />

LWFR-EXP15-002358<br />

LWFR-EXP15-002359-<br />

LWFR-EXP15-002369<br />

307 Chan – “Atopic Dermatitis in 2008” LWFR-EXP15-002370-<br />

308 Chen, JJ– “Detoxification of Reactive<br />

Aldehydes in Mitochondria”<br />

309 Co<strong>no</strong>lly, Rory B. – “Human Respiratory<br />

Tract Cancer Risks of Inhaled<br />

Formaldehyde”<br />

310 Co<strong>no</strong>lly, Rory B. – “Simulation<br />

Modeling of the Tissue Disposition of<br />

Formaldehyde”<br />

311 Costa, Solange – “Ge<strong>no</strong>toxic Damage in<br />

Pathology Anatomy Laboratory Workers<br />

Exposed to Formaldehyde”<br />

312 Cronin – “Formaldehyde is a Significant<br />

Allergen in Women with Hand Eczema”<br />

313 Dales, MD, Robert– “Quality of indoor<br />

residential air and health”<br />

314 Davydov, Vadim V. – “Age-Related<br />

Changes in Activity of Enzymes<br />

Catalyzing Oxidation-Reduction”<br />

315 Davydov, Vadim V. – “Possible Role of<br />

Alteration of Aldehyde's Scavenger<br />

Enzymes During Aging”<br />

316 de Groot – “Patch Test Reactivity to<br />

DMDM Hydantoin”<br />

317 Delfi<strong>no</strong>, Ralph J.– “Asthma Symptoms<br />

in Hispanic Children and Daily Ambient<br />

Exposures to Toxic and Criteria Air<br />

Pollutants”<br />

318 Delfi<strong>no</strong>, Ralph J. – “Epidemiologic<br />

Evidence for Asthma and Exposure to<br />

Air Toxics: Linkages between<br />

Occupational, Indoor and Community<br />

LWFR-EXP15-002418<br />

LWFR-EXP15-002419-<br />

LWFR-EXP15-002427<br />

LWFR-EXP15-002428-<br />

LWFR-EXP15-002445<br />

LWFR-EXP15-002446-<br />

LWFR-EXP15-002453<br />

LWFR-EXP15-002454-<br />

LWFR-EXP15-002463<br />

LWFR-EXP15-002464-<br />

LWFR-EXP15-002470<br />

LWFR-EXP15-002471-<br />

LWFR-EXP15-002476<br />

LWFR-EXP15-002477-<br />

LWFR-EXP15-002480<br />

LWFR-EXP15-002481-<br />

LWFR-EXP15-002487<br />

LWFR-EXP15-002488–<br />

LWFR-EXP15-002493<br />

LWFR-EXP15-002494-<br />

LWFR-EXP15-002503<br />

LWFR-EXP15-002504-<br />

LWFR-EXP15-002520


Air Pollution Research”<br />

319 d'Errico – “A Case-control Study on<br />

Occupational Risk Factors for Si<strong>no</strong>-<br />

Nasal Cancer”<br />

320 Eberlein-Konig – “Influence of Airborne<br />

Nitrogen Dioxide or Formaldehyde on<br />

Parameters of Skin Function”<br />

321 Edling, C. – “Formaldehyde and the<br />

Nasal Mucosa”<br />

322 Edling, C. – “Occupational exposure to<br />

Formaldehyde and Histopathological<br />

Changes in the Nasal Mucosa”<br />

323 Edling, C. – “Occupational Exposure to<br />

Formaldehyde”<br />

324 Erdei, Esther – “Indoor Air Pollutants<br />

and Immune Biomarkers among<br />

Hungarian Asthmatic Children”<br />

325 Fischer, A. – “Clinical Standardization<br />

of the TRUE Test Formaldehyde Patch”<br />

326 Fischer , A.– “Mediators of Asthma –<br />

Nitric Oxide”<br />

327 Fleming – “Patch Testing in Discoid<br />

Eczema”<br />

328 Flyvholm – “Allergic Contact Dermatitis<br />

From Formaldehyde”<br />

329 Franklin, Peter – “Raised Exhales Nitric<br />

Oxide in Healthy Children is Associated<br />

With Domestic Formaldehyde Levels”<br />

330 Garrett, M.H. – “Errata for Increased<br />

Risk of Allergy in Children due to<br />

Formaldehyde Exposure in Homes”<br />

331 Garrett, M.H. – “Increased risk of<br />

allergy in children due to <strong>formaldehyde</strong><br />

exposure in homes”<br />

332 Giwercman, Charlotte – “Classification<br />

of Atopic Hand Eczema and the<br />

Filaggrin Mutations”<br />

333 Gu, YH – “Long-term Exposure to<br />

Gaseous Formaldehyde Promotes<br />

allergen –specific<br />

IgE-mediated Immune Responses in a<br />

Murine Model”<br />

334 Hansen, Johnnie – “Formaldehyde and<br />

cancer Morbidity among male<br />

LWFR-EXP15-002521-<br />

LWFR-EXP15-002541<br />

LWFR-EXP15-002542-<br />

LWFR-EXP15-002544<br />

LWFR-EXP15-002545-<br />

LWFR-EXP15-002546<br />

LWFR-EXP15-002547-<br />

LWFR-EXP15-002554<br />

LWFR-EXP15-002555-<br />

LWFR-EXP15-002566<br />

LWFR-EXP15-002567-<br />

LWFR-EXP15-002578<br />

LWFR-EXP15-002579-<br />

LWFR-EXP15-002587<br />

LWFR-EXP15-002588-<br />

LWFR-EXP15-002598<br />

LWFR-EXP15-002599-<br />

LWFR-EXP15-002603<br />

LWFR-EXP15-002604-<br />

LWFR-EXP15-002615<br />

LWFR-EXP15-002616-<br />

LWFR-EXP15-002618<br />

LWFR-EXP15-002619-<br />

LWFR-EXP15-002620<br />

LWFR-EXP15-002621-<br />

LWFR-EXP15-002628<br />

LWFR-EXP15-002629-<br />

LWFR-EXP15-002632<br />

LWFR-EXP15-002633-<br />

LWFR-EXP15-002640<br />

LWFR-EXP15-00264-<br />

LWFR-EXP15-002647<br />

26


employees in Denmark”<br />

335 Hauptmann, Michael – “Mortality from<br />

Lymphohemtopoietic Malignancies<br />

Among Workers in Formaldehyde<br />

Industries”<br />

336 Hauptmann, Michale –“ Mortality from<br />

Solid Cancers among Workers in<br />

Formaldehyde Industries”<br />

337 Hayes, Richard B.- “Cancer of the nasal<br />

cavity and paranasal sinuses, and<br />

<strong>formaldehyde</strong> exposure”<br />

338 Hayes, Richard B.– “Mortality of <strong>US</strong><br />

Embalmers and Funeral Directors”<br />

339 Hayes, Richard B. – “Wood Related<br />

Occupations, Wood Dust Exposure and<br />

Si<strong>no</strong>nasal Cancer”<br />

340 Held, Elisabeth – “Contact Allergy to<br />

Cosmetics: Testing with Patients’ Own<br />

Products”<br />

341 Henderson, Edward M. – “SNOR and<br />

Wheeze: The Asthma Enzyme”<br />

342 Hester, Susan D. – “Formaldehyde<br />

Inducced Gene Expression in F344 Rat<br />

Nasal Respiratory Epithelium”<br />

343 Holmstrom, M. – “Histological Changes<br />

in the Nasal Mucosa in Persons<br />

Occupationally Exposed to<br />

Formaldehyde”<br />

344 Holmstrom, M. – “Histological Changes<br />

in the Nasal Mucosa in Rats after Long<br />

Term Exposure”<br />

345 Holmstrom, M. – “Respiratory<br />

Symptoms and Pathophysiological<br />

Effects of Occupational Exposure to<br />

Formaldehyde and Wood Dust”<br />

346 Hovding – “Contact Eczema Due to<br />

Formaldehyde in Resin Finished<br />

Textiles”<br />

347 Ionescu, Jean – “Experimental Chronic<br />

Obstructive Lung Disease.<br />

Bronchopulmonary Changes Induced<br />

in Rabbits by Prolonged Exposure to<br />

Formaldehyde”<br />

27<br />

LWFR-EXP15-002648-<br />

LWFR-EXP15-002656<br />

LWFR-EXP15-002657-<br />

LWFR-EXP15-002670<br />

LWFR-EXP15-002671-<br />

LWFR-EXP15-002676<br />

LWFR-EXP15-002677-<br />

LWFR-EXP15-002688<br />

LWFR-EXP15-002689-<br />

LWFR-EXP15-002694<br />

LWFR-EXP15-002695-<br />

LWFR-EXP15-002700<br />

LWFR-EXP15-002701-<br />

LWFR-EXP15-002704<br />

LWFR-EXP15-002705-<br />

LWFR-EXP15-002717<br />

LWFR-EXP15-002718-<br />

LWFR-EXP15-002730<br />

LWFR-EXP15-002731-<br />

LWFR-EXP15-002741<br />

LWFR-EXP15-002742-<br />

LWFR-EXP15-002747<br />

LWFR-EXP15-002748-<br />

LWFR-EXP15-002755<br />

LWFR-EXP15-002756-<br />

LWFR-EXP15-002771<br />

348 Jeffery, P.K. –“ Differences and LWFR-EXP15-002772-


Similarities between Chronic<br />

Obstructive Pulmonary Disease and<br />

Asthma”<br />

349 Kamata – “Results of a 28-Month<br />

Chronic Inhalation Toxicity Study of<br />

Formaldehyde in Male Fisher – 344<br />

Rats”<br />

350 Kerns, William D.- “Carci<strong>no</strong>genicity of<br />

Formaldehyde in Rata and Mice After<br />

Long-Term Inhalation Exposure”<br />

351 Kimbell, Julia – “Correlation of<br />

Regional Formaldehyde Flux Predictions<br />

with the Distribution of Formaldehydeinduced<br />

squamous metaplasia in F344<br />

Rat Nasal Passages”<br />

352 Kimbell, Julia-“ Nasal Dosimetry of<br />

Inhaled Gases and Particles”<br />

353 Krzyza<strong>no</strong>wski, Michal – “Chronic<br />

Respiratory Effects of Indoor<br />

Formaldehyde Exposure”<br />

354 Li<strong>no</strong>s – “Leukemia and Non-Hodgkin's<br />

Lymphoma Among Embalmers and<br />

Funeral Directors”<br />

355 Luce – “Si<strong>no</strong>nasal Cancer and<br />

Occupational<br />

Exposure to Formaldehyde and Other<br />

Substances”<br />

356 Maibach, Howard – “Formaldehyde -<br />

Effects on Animal and Human Skin”<br />

357 Maronpot, R.R. – “Toxicity of<br />

Formaldehyde Vapor in B6C3F1<br />

Mice”<br />

358 Matsunaga – “Ambient Formaldehyde<br />

Levels and Allergic Disorders Among<br />

Japanese Pregnant Women”<br />

359 Maurice, F. – “Anaphylactic Shock<br />

Caused by Formaldehyde”<br />

360 McGregor, D. – “Formaldehyde and<br />

Glutaraldehyde and Nasal Cytotoxicity”<br />

361 Mi – “Current asthma and respiratory<br />

symptoms among pupils in Shanghai,<br />

China”<br />

362 Mi – “Current asthma and respiratory<br />

symptoms among pupils in Shanghai,<br />

LWFR-EXP15-002785<br />

LWFR-EXP15-002786-<br />

LWFR-EXP15-002803<br />

LWFR-EXP15-002804-<br />

LWFR-EXP15-002814<br />

LWFR-EXP15-002815-<br />

LWFR-EXP15-002825<br />

LWFR-EXP15-002826-<br />

LWFR-EXP15-002830<br />

LWFR-EXP15-002831-<br />

LWFR-EXP15-002839<br />

LWFR-EXP15-002840-<br />

LWFR-EXP15-002841<br />

LWFR-EXP15-002842-<br />

LWFR-EXP15-002850<br />

LWFR-EXP15-002851-<br />

LWFR-EXP15-002855<br />

LWFR-EXP15-002856-<br />

LWFR-EXP15-002870<br />

LWFR-EXP15-002871-<br />

LWFR-EXP15-002877<br />

LWFR-EXP15-002878-<br />

LWFR-EXP15-002879<br />

LWFR-EXP15-002880-<br />

LWFR-EXP15-002896<br />

LWFR-EXP15-002897-<br />

LWFR-EXP15-002908<br />

LWFR-EXP15-002897-<br />

LWFR-EXP15-002908<br />

28


China”<br />

363 Monticello, Thomas M.-“ Cell<br />

Proliferation and Formaldehyde-Induced<br />

Respiratory Carci<strong>no</strong>genesis”<br />

364 Monticello, Thomas M. – “Effects of<br />

Formaldehyde Gas on the Respiratory<br />

Tract of Rhesus Monkeys”<br />

365 Nederost, Susan T. – “The Role of Patch<br />

Testing for Chemical and Protein<br />

Allergens in Atopic Dermatitis”<br />

366 Nielsen, G. Damgard – “Acute Airway<br />

Effects of Formaldehyde and Ozone in<br />

BALBc Mice”<br />

367 Olsen, J. H. – “Formaldehyde and the<br />

Risk of Squamous Cell Carci<strong>no</strong>ma of the<br />

Si<strong>no</strong>nasal Cavities”<br />

368 Olsen, J.H. –“ Formaldehyde induced<br />

symptoms in day care centers”<br />

369 Olsen, J.H. – “Occupational<br />

<strong>formaldehyde</strong> exposure and increased<br />

nasal cancer risk in man”<br />

370 Olsen, J. H. – “Occupational Risks of<br />

Si<strong>no</strong>nasal Cancer in Denmark”<br />

371 Ott, M. Gerald – “Lymphatic and<br />

Hematopoietic Tissue Cancer in<br />

Chemical Manufacturing Environment”<br />

372 Parmigiani - Ethotoxicology-“An<br />

Evolutionary Approach to the Study of<br />

Environmental Endocrine-Disrupting<br />

Chemicals”<br />

373 Pati, S.-“ Indoor Environmental Risk<br />

Factors for Asthma and Respiratory Ill<br />

Health in Preschool Children”<br />

374 Patty’s Toxicology – 5 th Edition –<br />

Volume 5<br />

“Aldehydes and Acetals”<br />

375 Pazdrak, Konrad- “Changes in nasal<br />

lavage fluid due to HCHO inhalation”<br />

376 Pedersen – “Occupational Hand Eczema<br />

from Formaldehyde in Price Labels”<br />

377 Pinkerton, L.E. – “Mortality among a<br />

cohort of garment workers exposed to<br />

Formaldehyde”<br />

29<br />

LWFR-EXP15-002915-<br />

LWFR-EXP15-002922<br />

LWFR-EXP15-002923-<br />

LWFR-EXP15-002935<br />

LWFR-EXP15-002936-<br />

LWFR-EXP15-002941<br />

LWFR-EXP15-002942-<br />

LWFR-EXP15-002953<br />

LWFR-EXP15-002954-<br />

LWFR-EXP15-002960<br />

LWFR-EXP15-002961-<br />

LWFR-EXP15-002966<br />

LWFR-EXP15-002967-<br />

LWFR-EXP15-002972<br />

LWFR-EXP15-002973-<br />

LWFR-EXP15-002979<br />

LWFR-EXP15-002980-<br />

LWFR-EXP15-002992<br />

LWFR-EXP15-002993-<br />

LWFR-EXP15-003000<br />

LWFR-EXP15-003001-<br />

LWFR-EXP15-003002<br />

LWFR-EXP15-003003-<br />

LWFR-EXP15-003016<br />

LWFR-EXP15-003017-<br />

LWFR-EXP15-003021<br />

LWFR-EXP15-003022-<br />

LWFR-EXP15-003024<br />

LWFR-EXP15-003025-<br />

LWFR-EXP15-003032<br />

378 Recio, Leslie – “Oncogene and Tumor LWFR-EXP15-003033-


Supressor Gene Alterations in Nasal LWFR-EXP15-003038<br />

Tumors”<br />

379 Roitt - Immu<strong>no</strong>logy Seventh Edition LWFR-EXP15-003039-<br />

LWFR-EXP15-003040<br />

380 Rostenberg, A. – “A Study of<br />

Eczematous Sensitivity to<br />

Formaldehyde”<br />

LWFR-EXP15-003041-<br />

LWFR-EXP15-003045<br />

381 Rumchev, K.B. –“ Domestic exposure to<br />

<strong>formaldehyde</strong> significantly increases the<br />

risk of asthma in young children”<br />

382 Rusch, George M. – “A 26 Week<br />

Inhalation Toxicity Study With<br />

Formaldehyde in the Monkey, Rat and<br />

Hamster”<br />

30<br />

LWFR-EXP15-003046-<br />

LWFR-EXP15-003051<br />

LWFR-EXP15-003052-<br />

LWFR-EXP15-003066<br />

383 Shaham - DNA-Protein Cross-Links LWFR-EXP15-003067-<br />

LWFR-EXP15-003076<br />

384 Sittig, Marshall – “Handbook of Toxic<br />

and Hazardous Chemicals and<br />

Carci<strong>no</strong>gens”<br />

LWFR-EXP15-003077-<br />

LWFR-EXP15-003082<br />

385 Smedje – “Asthma among secondary<br />

schoolchildren<br />

in relation to the school environment”<br />

386 Smedje – “Incidence of Asthma<br />

Diag<strong>no</strong>sis and Self-Reported Allergy”<br />

387 Stellman, Steven D. – “Cancer Mortality<br />

and Wood Dust Exposure Among<br />

Participants In The American Cancer<br />

Society Cancer Prevention Study-II”<br />

388 Stroup, Nancy E. – “Brain Cancer and<br />

Other Causes of Death in Anatomists”<br />

389 Swenberg, James A. –“ Induction of<br />

Squamous Cell Carci<strong>no</strong>mas of the Rat<br />

Nasal Cavity”<br />

390 Takahashi, Sachiko– “Prospective Study<br />

of Clinical Symptoms and Skin Test<br />

Reactions in Medical Students”<br />

391 Tavernier, Gael - IPEADAM study –<br />

“indoor endotoxin exposure”<br />

392 Thompson – “Mechanistic and Dose<br />

Considerations for Support Adverse<br />

Pulmonary Physiology”<br />

393 Thompson – “Mechanistic<br />

Considerations for HCHO induced<br />

bronchoconstriction”<br />

LWFR-EXP15-003083-<br />

LWFR-EXP15-003092<br />

LWFR-EXP15-003093-<br />

LWFR-EXP15-003100<br />

LWFR-EXP15-003102-<br />

LWFR-EXP15-003110<br />

LWFR-EXP15-003111-<br />

LWFR-EXP15-003118<br />

LWFR-EXP15-003119-<br />

LWFR-EXP15-003123<br />

LWFR-EXP15-003124-<br />

LWFR-EXP15-003131<br />

LWFR-EXP15-003132-<br />

LWFR-EXP15-003138<br />

LWFR-EXP15-003139-<br />

LWFR-EXP15-003144<br />

LWFR-EXP15-003145-<br />

LWFR-EXP15-003150


394 Til – “Evaluation of Oral Toxicity of<br />

Acetaldehyde and Formaldehyde”<br />

395 Til – “Two-Year Drinking-Water Study<br />

of Formaldehyde in Rats”<br />

396 <strong>US</strong> DHH – “Toxicology Profile for<br />

Formaldehyde”<br />

397 <strong>US</strong> EPA – “Formaldehyde Hazard<br />

Summary”<br />

398 Vaughan – “Formaldehyde and Cancers<br />

of the Pharynx, Sinus and Nasal Cavity<br />

1”<br />

399 Vaughan – “Formaldehyde and Cancers<br />

of the Pharynx, Sinus and Nasal Cavity<br />

2”<br />

400 Vaughan – “Occupational Exposure to<br />

Formaldehyde and Wood Dust and<br />

Nasopharyngeal Carci<strong>no</strong>ma copy”<br />

401 von Bub<strong>no</strong>ff – “Dendritic Cells and<br />

Atopic Eczema-Dermatitis Syndrome”<br />

Walrath – “Motality Patterns Among<br />

Embalmers”<br />

Wantke – “Exposure to gaseous HCHO<br />

induces<br />

IgE-Mediated sensitization to HCHO”<br />

West – “Non-Viral Risk Factors for<br />

Nasopharyngeal Carci<strong>no</strong>ma in the<br />

Phillippines- Results from a Case<br />

Control Study copy”<br />

Weston – “Type IV Reactions in the<br />

Skin”<br />

Wilmer – “Subacute 4-week Inhalation<br />

Toxicity Study”<br />

Wilmer – “Subchronic 13-week<br />

Inhalation Toxicity Study of<br />

Formaldehyde in Male Rats”<br />

World Health Organization -<br />

Environmental Health Criteria –<br />

Formaldehyde<br />

World Health Organization - IARC<br />

Mo<strong>no</strong>graphs on the Evaluation of<br />

Carci<strong>no</strong>genic Risks to Humans<br />

Woutersen – “Subchronic 13-Week<br />

Inhalation Toxicity Study of<br />

LWFR-EXP15-003151-<br />

LWFR-EXP15-003158<br />

LWFR-EXP15-003159-<br />

LWFR-EXP15-003170<br />

LWFR-EXP15-003171-<br />

LWFR-EXP15-003638<br />

LWFR-EXP15-003639-<br />

LWFR-EXP15-003643<br />

LWFR-EXP15-003644-<br />

LWFR-EXP15-003650<br />

LWFR-EXP15-003651-<br />

LWFR-EXP15-003655<br />

LWFR-EXP15-003656-<br />

LWFR-EXP15-003664<br />

LWFR-EXP15-003665-<br />

LWFR-EXP15-003670<br />

LWFR-EXP15-003671–<br />

LWFR-EXP15-003676<br />

LWFR-EXP15-003677-<br />

LWFR-EXP15-003682<br />

LWFR-EXP15-003683-<br />

LWFR-EXP15-003688<br />

LWFR-EXP15-003689-<br />

LWFR-EXP15-003693<br />

LWFR-EXP15-003694-<br />

LWFR-EXP15-003697<br />

LWFR-EXP15-003698-<br />

LWFR-EXP15-003705<br />

LWFR-EXP15-003706-<br />

LWFR-EXP15-003876<br />

LWFR-EXP15-003877-<br />

LWFR-EXP15-003877<br />

LWFR-EXP15-003878-<br />

LWFR-EXP15-003886<br />

31


Formaldehyde in Rats”<br />

Wuthrich – “Atopic Eczema - Genetics<br />

or Environment”<br />

Zhao – “Asthmatic Symptoms among<br />

Pupils in Relation to Winter Indoor and<br />

Outdoor Air Pollution”<br />

Zwart – “Cytotoxic and Adaptive Effects<br />

in Rat Nasal Epithelium”<br />

02-21-1989 - Formaldehyde Standard<br />

Clarification<br />

08-07-1987 - Cancer warning labels for<br />

<strong>formaldehyde</strong> and products containing<br />

<strong>formaldehyde</strong><br />

32<br />

LWFR-EXP15-003887-<br />

LWFR-EXP15-003893<br />

LWFR-EXP15-003894-<br />

LWFR-EXP15-003902<br />

LWFR-EXP15-003903-<br />

LWFR-EXP15-003916<br />

LWFR-EXP15-003917-<br />

LWFR-EXP15-003918<br />

LWFR-EXP15-003919-<br />

LWFR-EXP15-003920<br />

29 CFR 1910.1000-END LWFR-EXP15-003921-<br />

LWFR-EXP15-003940<br />

Affidavit of Patricia Williams in the LWFR-EXP15-003941-<br />

Trial of Alana Alexander and<br />

LWFR-EXP15-003942<br />

Christopher Cooper<br />

Casual Evidence of Carci<strong>no</strong>genicity<br />

from<br />

Ge<strong>no</strong>toxicity and Cytoxicity<br />

Documentation for Immediately<br />

Dangerous<br />

to Life or Health Concentrations<br />

(IDLHs) – 50000<br />

Formaldehyde - 1910.1048<br />

Formaldehyde - 5246168-312<br />

Formaldehyde presentation<br />

demonstrative evidence<br />

Hazard Communication – 1910<br />

IARC Mo<strong>no</strong>graphs Programme on the<br />

Evaluation of Carci<strong>no</strong>genic Risks to<br />

Humans pgs 9, 11, 15-17, 23, 33<br />

Intro to 29 CFR Part 1910, Occupational<br />

Exposure to Formaldehyde<br />

List of all the times analyzed strength of<br />

association in epidemiologic studies in<br />

toxic tort litigation<br />

Medical Surveillance - Formaldehyde -<br />

1910_1048 App C<br />

NIOSH 77-126a-f<br />

LWFR-EXP15-003943-<br />

LWFR-EXP15-003943<br />

LWFR-EXP15-003944-<br />

LWFR-EXP15-003945<br />

LWFR-EXP15-003946-<br />

LWFR-EXP15-003967<br />

LWFR-EXP15-003968-<br />

LWFR-EXP15-003969<br />

LWFR-EXP15-003970-<br />

LWFR-EXP15-004019<br />

LWFR-EXP15-004020-<br />

LWFR-EXP15-004042<br />

LWFR-EXP15-004043-<br />

LWFR-EXP15-004049<br />

LWFR-EXP15-004050-<br />

LWFR-EXP15-004051<br />

LWFR-EXP15-004052-<br />

LWFR-EXP15-004053<br />

LWFR-EXP15-004054-<br />

LWFR-EXP15-004057<br />

LWFR-EXP15-004058-


NIOSH Pocket Guide to Chemical<br />

Hazards<br />

NIOSH-Respirator Use Policy for<br />

Protection<br />

Against Carci<strong>no</strong>gens<br />

Null Hypothesis Sir Ronald Fisher0001<br />

OSHA Recognized Carci<strong>no</strong>gens<br />

OSHA Safety and Health Standards 29<br />

CFR 1910<br />

Reference Guide on Epidemiology pg<br />

333 and 358<br />

Reference Guide on Toxicology pgs<br />

336-337, 378, 407-408, 415<br />

Modern Epidemiology – 2 nd Edition –<br />

Causal Interference in Epidemiology<br />

Section 6-VI_Health Effects Discussion<br />

and Determination of Final PEL<br />

Ward, Kathleen – “A Comparison of<br />

Expression of Surface – bound<br />

Immu<strong>no</strong>globulin E on Antigen –<br />

presenting cells in cutaneous tissue<br />

between patients with allergic, irritant<br />

and atopic dermatitis”<br />

Zweiman – “The Late Phase Reaction -<br />

Role of IgE, its Receptor and Cytokines”<br />

Beane Mortality From<br />

Lyphohematopoietic Malingancies<br />

Zhang - Formaldehyde exposure and<br />

leukemia<br />

Quievryn - Loss of DNA - Protein<br />

Crosslinks from Formaldehyde<br />

Hauptmann 2009 - Mortality from<br />

Lymphohematopoietic Malignancies<br />

Coglia<strong>no</strong> - Advice of Formaldehyde and<br />

Glycol Ethers<br />

Coglia<strong>no</strong> - Summary of IARC<br />

Mo<strong>no</strong>graphs on Formaldehyde<br />

Barker - DNA Protein Crosslinks<br />

Merk - Significance of Formaldehyde<br />

Induced DNA Protein Cross links<br />

33<br />

LWFR-EXP15-004234<br />

LWFR-EXP15-004235-<br />

LWFR-EXP15-004244<br />

LWFR-EXP15-004245-<br />

LWFR-EXP15-004246<br />

LWFR-EXP15-004247-<br />

LWFR-EXP15-004249<br />

LWFR-EXP15-004250-<br />

LWFR-EXP15-004251<br />

LWFR-EXP15-004252-<br />

LWFR-EXP15–004259<br />

LWFR-EXP15-004260-<br />

LWFR-EXP15-004261<br />

LWDR-EXP15-004262-<br />

LWDR-EXP15-004267<br />

LWFR-EXP15-004268-<br />

LWFR-EXP15-004269<br />

LWFR-EXP15-004270-<br />

LWFR-EXP15-004829<br />

LWFR-EXP15-004830-<br />

LWFR-EXP15-004837<br />

LWFR-EXP15-004838-<br />

LWFR-EXP15-004843<br />

LWFR-EXP15-004846-<br />

LWFR-EXP15-004865<br />

LWFR-EXP15-004866-<br />

LWFR-EXP15-004884<br />

LWFR-EXP15-004885-<br />

LWFR-EXP15-004892<br />

LWFR-EXP15-004893-<br />

LWFR-EXP15-004905<br />

LWFR-EXP15-004906-<br />

LWFR-EXP15-004906<br />

LWFR-EXP15-004907-<br />

LWFR-EXP15-004911<br />

LWFR-EXP15-004912-<br />

LWFR-EXP15-004937<br />

LWFR-EXP15-004938-<br />

LWFR-EXP15-004947


Wright Trial Power point demonstrative<br />

evidence Chart on Formaldehyde<br />

concentrations and eczema<br />

Chart on Formaldehyde concentrations<br />

and cancers<br />

Chart on Formaldehyde concentrations<br />

and Ge<strong>no</strong>toxicity and Cytotoxicity<br />

Report of Patricia M. Williams PhD,<br />

DABT on Lyndon Wright<br />

Charts on error rate/false positives/false<br />

negatives of TRUE Test<br />

Chart on Reproducibility of TRUE Test<br />

results<br />

Diagram of chemical reactions in TRUE<br />

Test<br />

Chart on OSHA and gaseous<br />

Formaldehyde and eczema and cancer<br />

Chart on Scientific Literature and<br />

Cancers and Formaldehyde<br />

Chart on Sensitive Populations<br />

Chart on ATSDR Minimal Risk Levels<br />

Chart on Scientific Methodology<br />

Chart on DNA damage and<br />

consequences to the cell<br />

Chart on epidemiologic flaws of Cohort<br />

studies vs Case studies<br />

Reference Manual Scientific Evidence,<br />

2 nd Edition (2000)<br />

Gollhausen, et al., Reproducibility of<br />

Patch Test results- Comparison of TRUE<br />

Test, Journal of American Academy of<br />

Dermatology, 1989<br />

Dales, et al., Respiratory Health Effects<br />

of Home Dampness and Molds among<br />

Canadian Children, American Journal of<br />

Epidemiology, 1991.<br />

Riddle, HF, Prevalence of Respiratory<br />

Respiratory Symptoms and Sensitization<br />

by Mould Antigens among a group of<br />

Maltworkers, Brit. Journal of Ind. Med.<br />

(1974)<br />

Revankar, S, Clinical Implications of<br />

Mycotoxins and Stachybotrys,<br />

Southwestern Internal Medicine Conf.<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

LWFR-EXP 15-001117-<br />

LWFR-EXP15-001763<br />

LWFR-EXP 15-001764-<br />

LWFR-EXP15-001768<br />

LWFR-EXP 15-001769-<br />

LWFR-EXP15-001776<br />

LWFR-EXP 15-001777-<br />

LWFR-EXP15-001782<br />

LWFR-EXP 15-001783-<br />

LWFR-EXP15-001796<br />

34


(2003)<br />

Hendry, et al., Review of Mycotoxins in<br />

Indoor Air, Journal of Toxicology and<br />

Env. Science (1993)<br />

Zachariae, et al., ROAT- Mophology of<br />

Roat on Arm, Neck and Face in<br />

<strong>formaldehyde</strong> and diazolidinyl urea<br />

sensitive individuals, Contact Dermatitis<br />

(2006)<br />

Simon, Textbook of Forensic<br />

Psychiatry, American Psychiatric<br />

Publishing, Inc., Washington DC, 2004<br />

Leung, Donald YM, Role of IGE in<br />

Atopic Dermatitis, Current Opinions in<br />

immu<strong>no</strong>logy (1993)<br />

Rumchev, et al, Association of domestic<br />

exposure to volatile organic compounds<br />

with asthma in young children<br />

Rumchev, et al, Domestic Exposure to<br />

Formaldehyde significantly increases<br />

the risk of asthma in young children, Eur<br />

Respir J (2002)<br />

Ruoppi, et al., Nasal symptoms among<br />

residents in moldy housing, Scand. J.<br />

Work Environ Health (2003)<br />

Schacter, et al., A Study of Respiratory<br />

Effects from Exposure to 2.0 ppm<br />

Formaldehyde in Occupationally<br />

Exposed Workers, Environmental<br />

Research (1987)<br />

Scheynius, et al., Absence of specific IgE<br />

antibodies in allergic contact sensitivity<br />

to <strong>formaldehyde</strong>, Allergy (1993)<br />

Schnuch, et al., Quantitative patch and<br />

repeated open application testing in<br />

hydroxyisohexyl 3-cyclohexene<br />

carbohaldehyde sensitive-patients,<br />

Contact Dermatitis (2009)<br />

Sciandra, et al., Pleomorphic ade<strong>no</strong>ma<br />

of the lateral nasal wall: case report,<br />

Acta Otorhi<strong>no</strong>laryngologica (2008)<br />

Shin, et al., Chronic Rhi<strong>no</strong>sinustis: An<br />

enhanced immune response to<br />

ubiquitous airborne fungi, Journal of<br />

LWFR-EXP 15-001797-<br />

LWFR-EXP15-001812<br />

LWFR-EXP 15-001813-<br />

LWFR-EXP15-001817<br />

LWFR-GEN-000003 –<br />

LWFR-GEN-000014<br />

LWFR-EXP 15-001818-<br />

LWFR-EXP15-001824<br />

LWFR-EXP 15-001825-<br />

LWFR-EXP15-001832<br />

LWFR-EXP 15-001833-<br />

LWFR-EXP15-001838<br />

LWFR-EXP 15-001839-<br />

LWFR-EXP15-001846<br />

LWFR-EXP 15-001847-<br />

LWFR-EXP15-001867<br />

LWFR-EXP 15-001868-<br />

LWFR-EXP15-00<strong>1873</strong><br />

LWFR-EXP 15-001874-<br />

LWFR-EXP15-001885<br />

LWFR-EXP 15-001886-<br />

LWFR-EXP15-001889<br />

LWFR-EXP 15-001890-<br />

LWFR-EXP15-001897<br />

35


allergy and clinical immu<strong>no</strong>logy (2004)<br />

Shio<strong>no</strong>, Mutomi, Surgery for acute<br />

aortic dissection using gelatinresourcin-formalin<br />

glue, J. Artif. Organs<br />

(2008)<br />

Simoni, et al., Mould/dampness<br />

exposure at home is associated with<br />

respiratory disorders in Italian Children<br />

and adolescents, (2005)<br />

Yuotunde, et al., Si<strong>no</strong>nasal<br />

Malignancies: A 10-Year Review in a<br />

Tertiary Health Institution, Journal of<br />

the National Medical Association (2007)<br />

Skorge, et al., Indoor exposures and<br />

respiratory symptoms in a Norwegian<br />

community sample, Thorax (2004)<br />

Kwon, et al., Sooty Mold of Persimmon-<br />

Caused by Cladosporium cladospioides,<br />

Plant Pathol. J. (2003)<br />

Sosrose<strong>no</strong>, Wihaskoro, A review of the<br />

mechanisms of oral tolerance and<br />

immu<strong>no</strong>therapy, Journal of the Society<br />

of Medicine (1995)<br />

Speit, et al., The Human Lung Cell Line<br />

A549 Does Not Develop Adaptive<br />

Protection Against the DNA-Damaging<br />

Action of Formaldehyde, Env. And<br />

Molecular Mutogenes (2009)<br />

Takahashi, et al., Prospective study of<br />

clinical symptoms and skin test reactions<br />

in medical students exposed to<br />

<strong>formaldehyde</strong> gas, Japanese<br />

Dermatological Association (2007)<br />

Takigawa, et al., Reduction of Indoor<br />

Formaldehyde Concentrations and<br />

Subjective Symptoms in a Gross<br />

Anatomy Laboratory, Bull. Environ.<br />

Contam. Toxicol (2005)<br />

Fisher, Ronald A., The Design of<br />

Experiments, Harper Publishing<br />

Toomarian, et al., Histopathological<br />

evaluation of pulpotomy, Lasers Med.<br />

Sci. (2008)<br />

36<br />

LWFR-EXP15-001898-<br />

LWFR-EXP15-001902<br />

LWFR-EXP 15-001908-<br />

LWFR-EXP15-001916<br />

LWFR-EXP 15-001917-<br />

LWFR-EXP15-001920<br />

LWFR-EXP 15-001921-<br />

LWFR-EXP15-001928<br />

LWFR-EXP 15-001929-<br />

LWFR-EXP15-001931<br />

LWFR-EXP 15-001332-<br />

LWRF-EXP15-001936<br />

LWFR-EXP 15-001944-<br />

LWFR-EXP15-001951<br />

LWFR-EXP 15-001952-<br />

LWFR-EXP15-001959<br />

LWFR-EXP 15-001968-<br />

LWFR-EXP15-001971<br />

LWFR-EXP 15-001972-<br />

LWFR-EXP15-001973<br />

LWFR-EXP 15-001974-<br />

LWFR-EXP15-001981<br />

Tortorici, et al., Maxillary bone necrosis LWFR-EXP 15-001982-


following the use of <strong>formaldehyde</strong><br />

containing paste: management and case<br />

series, British Dental Journal (2007)<br />

Towers, et al., Maxillary sinusitis<br />

mimicking malignant disease, Oral.<br />

Surg. (1975)<br />

Jarvis, et al., Toxigenic Molds in Water<br />

Damaged Buildings, Journal of Nat.<br />

Prod. (1996)<br />

Sorenson, et al., Trichothecene<br />

Mycotoxins in Aerosolized- Conidia of<br />

Stachyboltrys Atra, Applied and<br />

Environ. Microbiology (1987)<br />

Fisher, et al., Fundamentals of<br />

Diag<strong>no</strong>stic Mycology, 1996<br />

Uba, et al., Prospective Study of<br />

Respiratory Effects of Formaldehyde<br />

Among Healthy and Asthmatic Medical<br />

Students, Am. Journal of Ind. Med.<br />

(1989)<br />

Ue<strong>no</strong>, Yoshio, The Toxicology of<br />

Mycotoxins, Critical Reviews in<br />

Toxicology<br />

Ue<strong>no</strong>, Yoshio, Trichothecenes Overview<br />

Address<br />

Van Hoogstraten, et al., Persistent<br />

Immune Tolerance to Nickel and<br />

Chromium by Oral Administration Prior<br />

to Cutaneous Sensitization, Journal of<br />

Investigative Dermatology (1992)<br />

Venn, et al., Effects of volatile organic<br />

compounds, damp, and and other<br />

environmental exposures in the home on<br />

wheezing illness in children, Thorax<br />

(2003)<br />

Vilarma and Maibach, Correlations of<br />

patch test reactivity and the repeated<br />

open application test<br />

(ROAT)/provocative use test (PUT),<br />

Food and Chemical Toxicology (2004)<br />

Vimpel, et al., The value of X-ray<br />

examination of the paranasal sinuses<br />

after epistaxis, Journal of Laryngology<br />

and Otology (1985)<br />

LWFR-EXP15-001984<br />

LWFR-EXP 15-001985-<br />

LWFR-EXP15-001991<br />

LWFR-EXP 15-001992-<br />

LWFR-EXP15-001993<br />

LWFR-EXP 15-001994-<br />

LWFR-EXP15-001999<br />

LWFR-EXP 15-002000-<br />

LWFR-EXP15-002003<br />

LWFR-EXP 15-002004-<br />

LWFR-EXP15-002015<br />

LWFR-EXP 15-002016-<br />

LWFR-EXP15-002049<br />

LWFR-EXP 15-002050-<br />

LWFR-EXP15-002060<br />

LWFR-EXP 15-002061-<br />

LWFR-EXP15-002071<br />

LWFR-EXP 15-002072-<br />

LWFR-EXP15-002079<br />

LWFR-EXP 15-002080-<br />

LWFR-EXP15-002087<br />

LWFR-EXP 15-002088-<br />

LWFR-EXP15-002094<br />

37


Von Bub<strong>no</strong>ff, et al., Dendric cells and<br />

atopic eczema/dermatitis syndrome, Skin<br />

and Eye<br />

Wahlberg, et al., Quantification and<br />

Specificity of the Repeated Open<br />

Application Test (ROAT), Acta Derm<br />

Venereol (1997)<br />

Wantke, et al., Formaldehyde and<br />

phe<strong>no</strong>l exposure during an anatomy<br />

dissection course: A possible source of<br />

IgE sensitization, Allergy (1996)<br />

Wantke, et al., Exposure to<br />

<strong>formaldehyde</strong> and phe<strong>no</strong>l during an<br />

dissecting course: sensitizing potency of<br />

<strong>formaldehyde</strong> in medical students,<br />

Allergy (2000)<br />

Wantke, et al., Exposure to<br />

<strong>formaldehyde</strong> and phe<strong>no</strong>l during<br />

anatomy dissecting course: sensitizing<br />

potency of <strong>formaldehyde</strong> in medical<br />

students, Allergy (2000)<br />

Ward, et al., A comparison of expression<br />

of surface-bound immu<strong>no</strong>globulin E on<br />

antigen-presenting cells in cutaneous<br />

tissue between patients with allergic,<br />

irritant and atopic dermatitis, Contact<br />

Dermatitis (1991)<br />

White, et al., Oral Tolerance to contact<br />

allergens: a common occurrence? A<br />

review, Contact Dermatitis (2007)<br />

Zaghi and Maibach, Quantitative<br />

Relationships Between Patch Test<br />

Reactivity and Use Test Reactivity: An<br />

Overview, Cutaneous and Ocular<br />

Toxicology (2008)<br />

Ziem and McTamney, Profile of Patients<br />

with Chemical Injury and Sensitivity,<br />

Environmental Health Perspectives<br />

(1997)<br />

Gibson, James, Formaldehdye Toxicity,<br />

(1983)<br />

88. Any and all articles identified and/or<br />

relied upon by Plaintiff and/or<br />

Defendant experts in the preparation of<br />

LWFR-EXP 15-002095-<br />

LWFR-EXP15-002100<br />

LWFR-EXP 15-002101-<br />

LWFR-EXP15-002106<br />

LWFR-EXP 15-002107-<br />

LWFR-EXP15-002112<br />

LWFR-EXP 15-002113-<br />

LWFR-EXP15-002117<br />

LWFR-EXP 15-002118-<br />

LWFR-EXP15-002122<br />

LWFR-EXP 15-002123-<br />

LWFR-EXP15-002130<br />

LWFR-EXP 15-002137-<br />

LWFR-EXP15-002145<br />

LWFR-EXP 15-002151-<br />

LWFR-EXP15-002160<br />

LWFR-EXP 15-002161-<br />

LWFR-EXP15-002176<br />

LWFR-EXP 15-002177-<br />

LWFR-EXP15-002178<br />

To be supplemented<br />

38


their reports.<br />

Expert<br />

Records and<br />

Files<br />

89. Affidavit and Weather Data of Lee E. LWFR-EXP1-000001 –<br />

Branscome, Ph.D., C.C.M.<br />

LWFR-EXP1-000122<br />

90. Curriculum Vitae of Lee E. Branscome,<br />

Ph.D., C.C.M.<br />

PSC 025205-<br />

PSC 025214<br />

92. Medical Records of Lyndon Wright and<br />

file of George Farber, M.D.<br />

LWFR-EXP2-000021 –<br />

LWFR-EXP2-000052<br />

93. Preliminary Report of Paul Hewett,<br />

Ph.D.<br />

LWFR-EXP3-000001 –<br />

LWFR-EXP3-000026<br />

Final Report of Paul Hewett, Ph.D. LWFR-EXP2-000027-<br />

LWFR-EXP2-000060<br />

Supplemental Report of Paul Hewitt, To be supplemented<br />

Ph.D. (to be produced)<br />

94. Curriculum Vitae of Paul Hewitt, Ph.D. PSC 025265-<br />

PSC 025269<br />

Paul Hewett August 20, 2008 Technical LWFR-EXP3-000170-<br />

Report in FEMA Formaldehyde LWFR-EXP3-000197<br />

Products Liability Litigation<br />

Paul Hewett Report for Gulf Stream / LWFR-EXP3-000198-<br />

Alexander Trial<br />

Letter from FEMA to Trailer Occupants<br />

Re: Formaldehyde levels found in their<br />

<strong>trailer</strong>s<br />

39<br />

LWFR-EXP3-000216<br />

PSC 019684-<br />

PSC 019692<br />

96. Deposition Testimony of Paul Hewett, To be supplemented<br />

Ph.D.<br />

98. Preliminary Report of Kenneth LWFR-EXP6-000001-<br />

Laughery, Ph.D.<br />

LWFR-EXP6-000006<br />

Final Report of Kenneth Laughery,<br />

Ph.D.<br />

LWFR-EXP6-000007-<br />

LWFR-EXP6-000013<br />

99. Curriculum Vitae of Kenneth Laughery,<br />

Ph.D.<br />

PSC 025282-<br />

PSC 025313<br />

103. Preliminary Report of Alexis Mallet, Jr. LWFR-EXP7-000001-<br />

LWFR-EXP7-000013<br />

Final Report of Alexis Mallet, Jr. LWFR-EXP7-000014-<br />

LWFR-EXP7-000144<br />

Photographs for Report of Alexis Mallet,<br />

Jr.<br />

LWFR-EXP7-000145-<br />

LWFR-EXP7-000184<br />

104. Curriculum Vitae of Alexis Mallet, Jr. PSC 025314-<br />

PSC 025324<br />

Alexis Mallet, Jr., emails re discussion LWFR-EXP7-009495-<br />

of Parish Permit<br />

LWFR-EXP7-009497


Alexis Mallet, Jr., emails re Newspaper<br />

Article on Orleans Parish Electrical<br />

Codes<br />

Letter from Blanco to Thomas, 09/23/05<br />

Alexis Mallet emails and attached letters<br />

concerning Permit Regulations in<br />

Orleans Parish<br />

Policies and Code Clarifications<br />

Shaw Daily Quality Control Report,<br />

11/29/05<br />

Shaw emails regarding Orleans Parish<br />

Permit and Code Requirements<br />

Mach 15 RV Air Condition<br />

RVP Installation Instructions for 8000<br />

Series Air Conditioners<br />

RVP Operation and Maintenance<br />

Instructions for 6000, 7000, and 8000<br />

Series Air Conditioners<br />

RVP Data Inquiry Sheet<br />

FEMA-Dubuclet Report 7/14/09<br />

Email from Wyatt Rankin to Alex<br />

Mallet, 5/19/09<br />

Bayseal CC<br />

Bayseal CC for Residential Builders<br />

Chemical Design, Closed Cell Spray<br />

Foam<br />

Green Home Builder Creates<br />

Environmentally Friendly Home with<br />

Closed Cell Foam<br />

EnviroFoam Insulation<br />

Dometic Installation Instructions<br />

Forest River Appliance Information<br />

Sheet<br />

Emails regarding Fluor Jacking<br />

Instructions<br />

40<br />

LWFR-EXP7-009503-<br />

LWFR-EXP7-009526<br />

LWFR-EXP7-009527-<br />

LWFR-EXP7-009545<br />

LWFR-EXP7-009503-<br />

LWFR-EXP7-009526<br />

LWFR-EXP7-009546-<br />

LWFR-EXP7-009547<br />

LWFR-EXP7-009548-<br />

LWFR-EXP7-009551<br />

LWFR-EXP7-009552<br />

LWFR-EXP7-009553-<br />

LWFR-EXP7-009554<br />

LWFR-EXP7-009555-<br />

LWFR-EXP7-009570<br />

LWFR-EXP7-009571-<br />

LWFR-EXP7-009578<br />

LWFR-EXP7-009579-<br />

LWFR-EXP7-009580<br />

LWFR-EXP7-009581-<br />

LWFR-EXP7-009582<br />

LWFR-EXP7-009602<br />

LWFR-EXP7-009603-<br />

LWFR-EXP7-009604<br />

LWFR-EXP7-009605-<br />

LWFR-EXP7-009606<br />

LWFR-EXP7-009607-<br />

LWFR-EXP7-009611<br />

LWFR-EXP7-009612-<br />

LWFR-EXP7-009613<br />

LWFR-EXP7-009614-<br />

LWFR-EXP7-009621<br />

LWFR-EXP7-009583-<br />

LWFR-EXP7-009601<br />

LWFR-EXP7-009614-<br />

LWFR-EXP7-009622<br />

LWFR-EXP7-009643-<br />

LWFR-EXP7-009644


Fluor FEMA Procedures<br />

LWFR-EXP7-009645-<br />

LWFR-EXP7-009655<br />

Important Information for Travel Trailer<br />

Occupants<br />

LWFR-EXP7-009656-<br />

LWFR-EXP7-009657<br />

Formaldehyde Levels in FEMA- LWFR-EXP7-009658-<br />

Supplied Trailers<br />

LWFR-EXP7-009659<br />

Suburban Gas Furnaces Installation LWFR-EXP7-009660-<br />

Instruction<br />

LWFR-EXP7-009688<br />

Emails regarding CH20 Information LWFR-EXP7-009689<br />

Information from Composite Panel LWFR-EXP7-009690-<br />

Association Website<br />

LWFR-EXP7-009708<br />

Maxx Fan Installation Instructions LWFR-EXP7-009709-<br />

LWFR-EXP7-009713<br />

Emails regarding Closed Cell Foam LWFR-EXP7-009714-<br />

LWFR-EXP7-009717<br />

Versi-Foam Systems<br />

LWFR-EXP7-009718-<br />

LWFR-EXP7-009732<br />

Chemical Design Product Catalog: LWFR-EXP7-009733-<br />

Closed Cell Spray Foam<br />

LWFR-EXP7-009747<br />

Tool Box Training: Proper Jacking LWFR-EXP7-009748<br />

Techniques<br />

Emails Regarding Shaw Jacking LWFR-EXP7-009749-<br />

Procedure<br />

LWFR-EXP7-009750<br />

MHRA Website on Moisture Field<br />

Study<br />

LWFR-EXP7-009751-<br />

LWFR-EXP7-009752<br />

MHRA Minimizing Moisture Problems LWFR-EXP7-009753-<br />

Report<br />

LWFR-EXP7-009799<br />

MHRA Report Page with Handwritten LWFR-EXP7-009800-<br />

Note<br />

LWFR-EXP7-009801<br />

Building your Louisiana House LWFR-EXP7-009802-<br />

LWFR-EXP7-009804<br />

Email regarding Gulf Stream Coach<br />

Construction<br />

LWFR-EXP7-009805-<br />

LWFR-EXP7-009806<br />

RESNET Standards Chapter Seven LWFR-EXP7-009850-<br />

LWFR-EXP7-009877<br />

RESNET National Home Energy Rating<br />

Technical Guidelines 12/28/05<br />

LWFR-EXP7-009878-<br />

LWFR-EXP7-009918<br />

Performance Work Statement: LWFR-EXP7-009927-<br />

Individual Assistance-Technical LWFR-EXP7-009945<br />

Assistance Contract<br />

Email from Alexis Mallet to Alexis LWFR-EXP7-009958-<br />

Mallet regarding Electronic Code of LWFR-EXP7-009959<br />

Federal Regulations<br />

Stephen Patterson and Madan Mahta, LWFR-EXP7-009960-<br />

41


Roofing Design and Practice<br />

Email from Orleans Parish re: Code<br />

Enforcement<br />

106. Trailer drawings by Alexis Mallet,<br />

Jr./Ervin Ritter<br />

Trailer Photographs by Alexis Mallet, Jr.<br />

Trailer Videos by Alexis Mallet, Jr.<br />

Trailer Images by Alexis Mallet, Jr.<br />

Data Logger Information by Alexis<br />

Mallet, Jr.<br />

42<br />

LWFR-EXP7-009962<br />

LWFR-EXP7-13951<br />

LWFR-EXP7-13933-<br />

LWFR-EXP7-13950<br />

LWFR-EXP7-004671-<br />

LWFR-EXP7-005396;<br />

LWFR-EXP7-005401-<br />

LWFR-EXP7-005513;<br />

LWFR-EXP7-005518-<br />

LWFR-EXP7-005546;<br />

LWFR-EXP7-005554-<br />

LWFR-EXP7-005571;<br />

LWFR-EXP7-005574-<br />

LWFR-EXP7-005725;<br />

LWFR-EXP7-005726-<br />

LWFR-EXP7-006465;<br />

LWFR-EXP7-010628-<br />

LWFR-EXP7-010942;<br />

LWFR-EXP7-010999-<br />

LWFR-EXP7-011539;<br />

LWFR-EXP7-011541-<br />

LWFR-EXP7-011629;<br />

LWFR-EXP7-011660-<br />

LWFR-EXP7-011661;<br />

LWFR-EXP7-011749-<br />

LWFR-EXP7-011816;<br />

LWFR-EXP7-011822-<br />

LWFR-EXP7-012292;<br />

LWFR-EXP7-012782-<br />

LWFR-EXP7-013440;<br />

LWFR-EXP7-013441-<br />

LWFR-EXP7-013932<br />

LWFR-EXP7-005397;<br />

LWFR-EXP7-005398;<br />

LWFR-EXP7-005399;<br />

LWFR-EXP7-005400;<br />

LWFR-EXP7-008043-<br />

LWFR-EXP7-009430<br />

1 LWFR-EXP7-012293-<br />

1 LWFR-EXP7-012370;<br />

2 LWFR-EXP7-012371-<br />

2 LWFR-EXP7-012448;<br />

3 LWFR-EXP7-012449-<br />

3 LWFR-EXP7-012522;


4 LWFR-EXP7-012523-<br />

4 LWFR-EXP7-012600;<br />

5 LWFR-EXP7-012601-<br />

5 LWFR-EXP7-012678;<br />

6 LWFR-EXP7-012679-<br />

6 LWFR-EXP7-012756<br />

Ritter Consulting Engineers Handwritten<br />

Notes<br />

LWFR-EXP7-011817-<br />

LWFR-EXP7-011821<br />

109. Preliminary Report of Lawrence G.<br />

Miller, M.D., M.P.H.<br />

LWFR-EXP8-000001-<br />

LWFR-EXP8-000009<br />

Final Report of Lawrence G. Miller, LWFR-EXP8-000010<br />

M.D., M.P.H.<br />

LWFR-EXP8-000019<br />

Supplemental Report of Lawrence G. LWFR-EXP8-000108-<br />

Miller, M.D., M.P.H.<br />

LWFR-EXP8-000109<br />

110. Curriculum Vitae of Lawrence G.<br />

Miller, M.D., M.P.H.<br />

PSC 025360-<br />

PSC 025375<br />

Temporary Medical License for Dr. To be supplemented<br />

Lawrence Miller<br />

113. Exhibits from the deposition of To be supplemented<br />

Lawrence G. Miller, M.D., M.P.H.<br />

114. Preliminary Report of Charles David LWFR-EXP9-000001-<br />

Moore, P.E. P.L.S.<br />

LWFR-EXP9-000004<br />

Final Report of Charles David Moore, LWFR-EXP5-000005-<br />

P.E. P.L.S.<br />

LWFR-EXP5-000042<br />

115. Curriculum Vitae of Charles David<br />

Moore, P.E. P.L.S.<br />

PSC 025346-<br />

PSC 025349<br />

Construction Manuals (Manual of Steel LWFR-EXP5-000457-<br />

Construction, Minimum Design Loads, LWFR-EXP5-000459<br />

Timber Construction Manual)<br />

119. Preliminary Report of Ervin Ritter, P.E. LWFR-EXP10-000001-<br />

LWFR-EXP10-000007<br />

Final Report of Ervin Ritter, P.E. LWFR-EXP10-000008-<br />

LWFR-EXP10-000117<br />

120. Curriculum Vitae of Ervin Ritter, P.E. PSC 025350-<br />

PSC 025354<br />

121. Reliance Materials and File of Ervin To be supplemented<br />

Ritter, P.E.<br />

122. Deposition Testimony of Ervin Ritter, To be supplemented<br />

P.E.<br />

123. Exhibits from the deposition of Ervin To be supplemented<br />

Ritter, P.E.<br />

All photographs by Ervin Ritter LWFR-EXP10-000118-<br />

LWFR-EXP10-002068<br />

124. Preliminary Report of William D. Scott, LWFR-EXP11-000001-<br />

43


P.E., C.H.M.M.<br />

LWFR-EXP11-000042<br />

Final Report of William D. Scott, P.E., LWFR-EXP11-000043-<br />

C.H.M.M.<br />

LWFR-EXP11-000135<br />

125. Curriculum Vitae of William D. Scott, PSC 025355-<br />

P.E., C.H.M.M.<br />

PSC 025368<br />

126. Reliance Materials and File of William To be supplemented<br />

D. Scott, P.E., C.H.M.M.<br />

127. Deposition Testimony of William D. To be supplemented<br />

Scott, P.E. C.H.M.M.<br />

128. Exhibits from the deposition of William To be supplemented<br />

D. Scott, P.E., C.H.M.M.<br />

129. Microbial Growth Report by W.D. Scott To be supplemented<br />

and Associates<br />

130. Preliminary Report of Edward H. LWFR-EXP12-000001-<br />

Shwery, Ph.D.<br />

LWFR-EXP12-000011<br />

Preliminary Report of Edward H. LWFR-EXP12-000012-<br />

Shwery, Ph.D.<br />

LWFR-EXP12-000016<br />

131. Curriculum Vitae of Edward H. Shwery,<br />

Ph.D.<br />

PSC 025369-<br />

PSC 025391<br />

Edward H. Shwery Testing Raw Data LWFR-EXP12-000061-<br />

and Notes<br />

LWFR-EXP12-000128<br />

132. Reliance Materials and File of Edward To be supplemented<br />

H. Shwery, Ph.D.<br />

133. Deposition Testimony of Edward H. To be supplemented<br />

Shwery, Ph.D.<br />

134. Exhibits from the deposition of Edward To be supplemented<br />

H. Shwery, Ph.D.<br />

135. Preliminary Report of Stephen Smulski,<br />

Ph.D.<br />

LWFR-EXP13-000001-<br />

LWFR-EXP13-000022<br />

Final Report of Stephen Smulski, Ph.D. LWFR-EXP13-000023-<br />

LWFR-EXP13-000061<br />

136. Curriculum Vitae of Stephen Smulski, PSC 025392-<br />

Ph.D.<br />

PSC 025406<br />

Emails between Stephen Smulski and To be supplemented<br />

Composite Panel Association<br />

137. Reliance Materials and File of Stephen To be supplemented<br />

Smulski, Ph.D.<br />

Additional Reliance Documents, <strong>no</strong>t yet To be supplemented<br />

produced by Stephen Smulski, Ph.D.<br />

Photographs by Stephen Smulski, Ph.D. LWFR-EXP13-004164<br />

LWFR-EXP13-004354<br />

138. Deposition Testimony of Stephen To be supplemented<br />

Smulski, Ph.D.<br />

139. Exhibits from the deposition of Stephen To be supplemented<br />

44


Smulski, Ph.D.<br />

140. Preliminary Report of Patricia M. LWFR-EXP15-000001-<br />

Williams, Ph.D. D.A.B.T.<br />

LWFR-EXP15-000054<br />

Final Report of Patricia M. Williams, LWFR-EXP15-000055-<br />

Ph.D., D.A.B.T.<br />

LWFR-EXP15-000130<br />

141. Curriculum Vitae of Patricia M. PSC 025407-<br />

Williams, Ph.D., D.A.B.T.<br />

PSC 025437<br />

Fee Schedule of Patricia M. Williams, PSC 025438<br />

Ph.D., D.A.B.T.<br />

List of Testimonies of Patricia M.<br />

Williams, Ph.D., D.A.B.T.<br />

PSC 025439-<br />

PSC 025440<br />

142. Reliance Material and File of Patricia M. To be supplemented<br />

Williams, Ph.D., D.A.B.T.<br />

143. Deposition Testimony of Patricia M. To be supplemented<br />

Williams, Ph.D., D.A.B.T.<br />

144. Exhibits from the deposition of Patricia To be supplemented<br />

M. Williams, Ph.D., D.A.B.T.<br />

145. Preliminary Report of Paul LaGrange LWFR-EXP5-000001-<br />

LWFR-EXP5-000002<br />

Final Report of Paul LaGrange<br />

LWFR-EXP5-000003-<br />

LWFR-EXP5-000316<br />

Supplemental Report of Paul LaGrange To be supplemented<br />

146. Curriculum Vitae of Paul LaGrange PSC 026031-<br />

PSC 026034<br />

Fee Schedule of Paul LaGrange PSC 026035<br />

List of Testimonies of Paul LaGrange PSC 026036<br />

147. Reliance Materials and File of Paul To be supplemented<br />

LaGrange<br />

Additional Documents of Paul LaGrange LWFR-EXP5-000317-<br />

LWFR-EXP5-000570<br />

Photographs by Paul LaGrange LWFR-EXP5-000595-<br />

LWFR-EXP5-001243;<br />

LWFR-EXP5-001244-<br />

LWFR-EXP5-001271<br />

Videos by Paul LaGrange<br />

LWFR-EXP5-000572;<br />

LWFR-EXP5-000575;<br />

LWFR-EXP5-000573;<br />

LWFR-EXP5-000574;<br />

LWFR-EXP5-000578<br />

Initial Place Holding Report<br />

LWFR-EXP5-000576-<br />

LWFR-EXP5-000577<br />

Paul LaGrange Handwritten Notes; LWFR-EXP5-000579-<br />

Inspection Notes<br />

LWFR-EXP5-000594<br />

LaGrange Report LWFR-EXP 5-000001 –<br />

45


LWFR-EXP 5-000316;<br />

PSC 026031 –<br />

PSC 026036<br />

Dometic Installation Instructions FR-LTW-EXP06-107751<br />

–<br />

FR-LTW-EXP06-107769<br />

LaGrange Video Animation with You LWFR-EXP 5-001277<br />

Tube link<br />

LaGrange HVAC Load Calculations<br />

(Corrected Manual J Load)<br />

LWFR-EXP 5-001278 –<br />

LWFR-EXP 5-001296<br />

LaGrange Supplemental Letter of<br />

Clarification<br />

LWFR-EXP 5-001272 –<br />

LWFR-EXP 5-001273<br />

LaGrange Tectite Blower Door Test<br />

Report<br />

LWFR-EXP 5-001274 –<br />

LWFR-EXP 5-001276<br />

148. Deposition Testimony of Paul LaGrange To be supplemented<br />

149. Exhibits from the deposition of Paul To be supplemented<br />

LaGrange<br />

150. Preliminary Report of Dr. Richard A LWFR-EXP14-000001-<br />

Spector<br />

LWFR-EXP14-000004<br />

Final Report of Dr. Richard A. Spector LWFR-EXP14-000005-<br />

LWFR-EXP14-000015<br />

151. Curriculum Vitae of Dr. Richard A. PSC 026027-<br />

Spector<br />

PSC 026030<br />

152. Reliance Materials and File of Dr. To be supplemented<br />

Richard A. Spector<br />

153. Deposition Testimony of Dr. Richard A. To be supplemented<br />

Spector<br />

154. Exhibits from the deposition of Dr. To be supplemented<br />

Richard A. Spector<br />

155. Any supplemental Affidavits or Reliance To be supplemented<br />

Material by Plaintiff’s or Defendants’<br />

Experts<br />

156. Any deposition testimony provided by To be supplemented<br />

any and all plaintiff and/or deposition<br />

fact and/or expert witness in this matter.<br />

157. Any and all demonstrative evidence to To be supplemented<br />

be developed and/or utilized by<br />

Plaintiff’s experts at trial<br />

158. Any additional exhibits identified at To be supplemented<br />

deposition of any expert or fact witness<br />

in this matter.<br />

Any document to be identified by<br />

Plaintiff in the ongoing discovery and<br />

deposition process<br />

To be supplemented<br />

46


All Photographs taken by Plaintiff or<br />

Plaintiff’s Experts<br />

Any Plaintiff supplementation of any<br />

report and supplementing documents<br />

which may occur<br />

Any and all Plaintiff demonstrative aids<br />

for trial to be exchanged at the<br />

appropriate time<br />

Testing<br />

Database<br />

159. Formaldehyde Testing Database<br />

Testing<br />

Documents<br />

prepared by the PSC<br />

Bill Scott Testing Data, October, 2008<br />

Bill Scott Testing Data, August, 2009<br />

Mold Testing Data<br />

Plaintiff’s Testing Protocol<br />

All Testing Results Produced Relating to<br />

Lyndon Wright Unit<br />

Inspection in<br />

Melville, LA<br />

160. Photographs taken by<br />

Plaintiffs/Plaintiff’s Experts during<br />

destructive testing at FEMA<br />

Staging/Storing Facility in Melville,<br />

Louisiana.<br />

161. Video taken by Plaintiff/Plaintiff’s<br />

Experts during the destructive testing at<br />

FEMA Staging/Storage Facility in<br />

Melville, Louisiana.<br />

162. Photographs taken by<br />

Defendants/Defendants’ Experts during<br />

destructive testing.<br />

163. Video taken by Defendants/Defendants’<br />

Experts during destructive testing.<br />

164. Animations created by C4 Animation<br />

(Reagan Johnson)<br />

166. Results of all testing and inspection of<br />

the Forest River/Wright unit including,<br />

but <strong>no</strong>t limited to, air sampling,<br />

temperature, humidity, and photographs<br />

thereof<br />

47<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

168. Test Results of mold sampling To be supplemented


performed by WD Scott Group during<br />

destructive testing.<br />

169. Test Results of mold sampling taken by<br />

Defendants’ Experts during destructive<br />

testing.<br />

171. Exemplar of a Personal Monitoring<br />

System for Aldehydes (Exemplar<br />

Passive Dosimeter)<br />

172. Exemplars of Various Component Wood<br />

Products from Lyndon Wright Forest<br />

River Travel Trailer.<br />

173. Exemplars of Alternative Wood<br />

Products from Lyndon Wright Forest<br />

River Travel Trailer.<br />

174. All additional measurements to<br />

measurements and graphic<br />

representations of Lyndon Wright <strong>trailer</strong><br />

to be identified<br />

Forest River,<br />

Inc.<br />

175. Forest River, Inc., Lyndon Wright <strong>trailer</strong><br />

unit file<br />

176. Any and all Class certification Forest<br />

River deposition testimony<br />

177. Any and all Class certification Forest<br />

River deposition exhibits / documents<br />

produced<br />

48<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

FR-0151924<br />

FR-151946<br />

To be supplemented<br />

To be supplemented<br />

178. Forest River Owner’s Manual FOREST 0002399-<br />

FOREST 0002483<br />

Forest River Draft Testing Protocol<br />

FR-LTW-EXP06-06698-<br />

FR-LTW-EXP06-006701<br />

179. FEMA Specifications FOREST 0003284-<br />

FOREST 0003289<br />

180. NACS Correspondence and Solicitation FOREST 0002503-<br />

and emails<br />

FOREST 0002508;<br />

181. Any and all Internal emails and<br />

communications relevant to FEMA<br />

production<br />

Liberty Building Emails<br />

FOREST 0003521<br />

To be supplemented<br />

FR-LTW-EXP06-<br />

019602;<br />

FR-LTW-EXP06-<br />

019676-<br />

FR-LTW-EXP06-


Email between John Odom and Don<br />

Snell 10/22/09 (Exhibit 20 of Liberty<br />

Deposition)<br />

ANSI/ASHRAE Standard 62.2-2004, pp.<br />

9-10<br />

49<br />

019678;<br />

FR-LTW-EXP06-<br />

019631-<br />

FR-LTW-EXP06-<br />

019634;<br />

FR-LTW-EXP06-<br />

019688-<br />

FR-LTW-EXP06-<br />

019698;<br />

FR-LTW-EXP06-<br />

019648-<br />

FR-LTW-EXP06-<br />

019653;<br />

FR-LTW-EXP06-<br />

019637-<br />

FR-LTW-EXP06-<br />

019644;<br />

FR-LTW-EXP06-<br />

019609-<br />

FR-LTW-EXP06-<br />

019616;<br />

FR-LTW-EXP06-<br />

019603-<br />

FR-LTW-EXP06-019608<br />

To be supplemented<br />

FR-LTW-EXP06-<br />

006498-<br />

FR-LTW-EXP06-006499<br />

To be supplemented<br />

182. Any and all Deposition Testimony of<br />

Elton Kiefer<br />

183. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Elton Kiefer<br />

184. Any and all Deposition Testimony of To be supplemented<br />

Jeff Burrian<br />

185. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Jeff Burrian<br />

186. Affidavits of Norman Nelson To be supplemented<br />

187. Curriculum Vitae of Norman Nelson FR-LTW-EXP06-<br />

019726-<br />

188. Reliance Materials and File of Norman<br />

Nelson<br />

FR-LTW-EXP06-019729<br />

To be supplemented


189. Any and all Deposition Testimony of To be supplemented<br />

Norman Nelson<br />

190. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Norman Nelson<br />

191. Report of G. Graham Allan LTW-EXP01-000001-<br />

LTW-EXP01-000003<br />

192. Curriculum Vitae of G. Graham Allan LTW-EXP01-000004-<br />

LTW-EXP01-000036<br />

Fee Schedule of G. Graham Allen LTW-EXP01-000037<br />

List of Testimonies of G. Graham Allen LTW-EXP01-000038<br />

193. Reliance Materials and File of G. To be supplemented<br />

Graham Allan<br />

194. Any and all Deposition Testimony of G. To be supplemented<br />

Graham Allan<br />

195. Any and all Exhibits from the To be supplemented<br />

deposition(s) of G. Graham Allan<br />

196. Report of Philip Cole, M.D. FR-LTW-EXP02-<br />

000001-<br />

FR-LTW-EXP02-000020<br />

Report of Philip Cole, M.D.<br />

FR-LTW-EXP02-<br />

000041-<br />

FR-LTW-EXP02-000060<br />

197. Curriculum Vitae of Philip Cole, M.D. FR-LTW-EXP02-<br />

000021-<br />

FR-LTW-EXP02-000037<br />

List of Testimonies of Philip Cole, M.D. FR-LTW-EXP02-000038<br />

FR-LTW-EXP02-000040<br />

198. Reliance Materials and File of Philip To be supplemented<br />

Cole, M.D.<br />

199. Any and all Deposition Testimony of To be supplemented<br />

Philip Cole, M.D.<br />

200. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Philip Cole, M.D.<br />

201. Affidavits of Nathan T. Dorris To be supplemented<br />

202. Curriculum Vitae of Nathan T. Dorris FR-LTW-EXP03-<br />

000001-<br />

FR-LTW-EXP03-000015<br />

203. Reliance Materials and File of Nathan T. To be supplemented<br />

Dorris<br />

204. Any and all Deposition Testimony of To be supplemented<br />

Nathan T. Dorris<br />

205. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Nathan T. Dorris<br />

206. Report of William L. Dyson FR-LTW-EXP04-<br />

50


000001-<br />

FR-LTW-EXP04-000019<br />

207. Curriculum Vitae of William L. Dyson FR-LTW-EXP04-<br />

000020-<br />

FR-LTW-EXP04-000023<br />

Fee Schedule of William L. Dyson<br />

List of Testimonies of Williams L.<br />

Dyson<br />

208. Reliance Materials and File of William<br />

L. Dyson<br />

51<br />

FR-LTW-EXP04-000024<br />

FR-LTW-EXP04-<br />

000025-<br />

FR-LTW-EXP04-000031<br />

FR-LTW-EXP04-<br />

000001-<br />

FR-LTW-EXP04-000567<br />

209. Any and all Deposition Testimony of To be supplemented<br />

William L. Dyson<br />

210. Any and all Exhibits from the To be supplemented<br />

deposition(s) of William L. Dyson<br />

211. Report of Thomas Fribley FR-LTW-EXP05-<br />

000001-<br />

FR-LTW-EXP05-000003<br />

212. Curriculum Vitae of Thomas Fribley FR-LTW-EXP05-<br />

000004-<br />

FR-LTW-EXP05-000008<br />

213. Reliance Materials and File of Thomas<br />

Fribley<br />

FR-LTW-EXP05-<br />

000001-<br />

FR-LTW-EXP05-001454<br />

214. Any and all Deposition Testimony of To be supplemented<br />

Thomas Fribley<br />

215. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Thomas Fribley<br />

216. Affidavits of Don Snell To be supplemented<br />

217. Curriculum Vitae of Don Snell FR-LTW-EXP06-<br />

019731-<br />

FR-LTW-EXP06-019735<br />

218. Reliance Materials and File of Don Snell To be supplemented<br />

219. Any and all Deposition Testimony of To be supplemented<br />

Don Snell<br />

220. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Don Snell<br />

221. Affidavits of Kenneth B. Smith To be supplemented<br />

222. Curriculum Vitae of Kenneth B. Smith LTW-EXP07-000001-<br />

LTW-EXP07-000002<br />

Fee Schedule of Kenneth B. Smith LTW-EXP07-000003-<br />

LTW-EXP07-000004<br />

223. Reliance Materials and File of Kenneth LTW-EXP07-000001-


B. Smith LTW-EXP07-000291<br />

224. Any and all Deposition Testimony of To be supplemented<br />

Kenneth B. Smith<br />

225. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Kenneth B. Smith<br />

226. Report of Dr. John W. Thompson FR-LTW-EXP08-<br />

000001-<br />

FR-LTW-EXP08-000015<br />

227. Curriculum Vitae of Dr. John W.<br />

Thompson<br />

FR-LTW-EXP08-<br />

000016-<br />

List of Testimonies of Dr. John W.<br />

Thompson<br />

Fee Schedule of Dr. John W. Thompson<br />

228. Reliance Materials and File of Dr. John<br />

W. Thompson<br />

52<br />

FR-LTW-EXP08-000037<br />

FR-LTW-EXP08-<br />

000038-<br />

FR-LTW-EXP08-000052<br />

FR-LTW-EXP08-000053<br />

FR-LTW-EXP08-<br />

000001-<br />

FR-LTW-EXP08-002293<br />

229. Any and all Deposition Testimony of Dr. To be supplemented<br />

John W. Thompson<br />

230. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Dr. John W. Thompson<br />

231. Affidavits of Tony Watson To be supplemented<br />

232. Curriculum Vitae of Tony Watson FR-LTW-EXP09-<br />

000169-<br />

FR-LTW-EXP09-000170<br />

FR-LTW-EXP09-000171<br />

List of Trial Testimonies of Tony<br />

Watson<br />

233. Reliance Materials and File of Tony To be supplemented<br />

Watson<br />

234. Any and all Deposition Testimony of To be supplemented<br />

Tony Watson<br />

235. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Tony Watson<br />

236. Affidavits of H. James Wedner, M.D. Bates Range to be<br />

supplied upon receipt of<br />

same<br />

237. Curriculum Vitae of H. James Wedner,<br />

M.D.<br />

238. Reliance Materials and File of H. James<br />

Wedner, M.D.<br />

Bates Range to be<br />

supplied upon receipt of<br />

same<br />

Bates Range to be<br />

supplied upon receipt of<br />

same<br />

239. Any and all Deposition Testimony of H. To be supplemented


James Wedner, M.D.<br />

240. Any and all Exhibits from the To be supplemented<br />

deposition(s) of H. James Wedner, M.D.<br />

241. Any and all Deposition Testimony of To be supplemented<br />

Jaime Albrecht<br />

242. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Jaime Albrecht<br />

243. Any and all Deposition Testimony of To be supplemented<br />

Jim Foltz<br />

244. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Jim Foltz<br />

245. Any and all Deposition Testimony of To be supplemented<br />

Forest River Warranty Officer, yet to be<br />

designated<br />

246. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Forest River Warranty<br />

Deponent, yet to be designated<br />

247. Any and all Deposition Testimony of To be supplemented<br />

Corporate Representative of Forest<br />

River, Doug Gaeddert<br />

248. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Corporate<br />

Representative of Forest River, Doug<br />

Gaeddert<br />

249. Any and all Deposition Testimony of To be supplemented<br />

any and/or all Corporate Representative<br />

of Forest River, yet to be designated<br />

250. Any and all Exhibits from the To be supplemented<br />

deposition(s) of any and/or all Corporate<br />

Representative of Forest River, yet to be<br />

designated<br />

251. Any and all documentation identified by To be supplemented<br />

defendant’s experts in the preparation of<br />

their reports and/or testimony.<br />

252. Any and all exhibits identified and/or To be supplemented<br />

used and/or relied upon by defendant’s<br />

in the ongoing litigation of this matter.<br />

Pricing costs for 32 BHLE FOREST 0003171-<br />

FOREST 0003249<br />

32 BHLE Diagrams and Specs FOREST 0003250-<br />

FOREST 0003299;<br />

FOREST 0003366-<br />

FOREST 0003391<br />

Lippert 32 BHLE Diagrams FOREST 0003140;<br />

53


FOREST 0003344-<br />

FOREST 0003345;<br />

FOREST 0003351<br />

Any and all blueprints and design To be supplemented<br />

documents produced at deposition<br />

255. Internal Forest River Memorandum FOREST 0003294-<br />

regarding proposed production schedule FOREST 0003299<br />

256. September 1, 2005, NACS/FEMA To be supplemented<br />

Solicitation and Specifications<br />

257. Handwritten designs, drawings, and To be supplemented<br />

<strong>no</strong>tes for FEMA units<br />

258. NACS/Forest River FEMA To be supplemented<br />

Specifications documents<br />

259. 2004 Email from NACS to Forest River To be supplemented<br />

regarding FEMA Trailer Production<br />

Specifications<br />

260. November 2006 Elton Kiefer <strong>no</strong>tes To be supplemented<br />

regarding Patrick and Adorn switching<br />

to LFE in early 2007<br />

261. September 1, 2005 email Ty Miller to To be supplemented<br />

Doug Gaeddert and Tom Martin<br />

regarding California production<br />

Deposition Transcript of Brian Deckle, P. 79-81<br />

NACS<br />

Warranty Documents and Repair To be supplemented<br />

Documents<br />

MSDS’s FOREST 0002609-<br />

FOREST 0002619<br />

Congressional Statement of Pete Liegl To be supplemented<br />

September 1, 2005, Production FOREST 0003449<br />

Memorandum<br />

Forest River’s responses to Discovery To be supplemented<br />

Requests<br />

Forest River Inspection Protocol To be supplemented<br />

Forest River Testing Methodologies FR-LTW-EXP06-006696<br />

from Liberty (Operational Pressures)<br />

Forest River Testing Methodologies<br />

from Liberty (Testing Methodologies)<br />

FR-LTW-EXP06-<br />

003857-<br />

FR-LTW-EXP06-003862<br />

Forest River Periodic Maintenance Chart FR-LTW-EXP06-017924<br />

Liberty Handwritten <strong>no</strong>tes starting FR-LTW-EXP06-<br />

07/30/09<br />

004902-<br />

FR-LTW-EXP06-004920<br />

Liberty Schematics of Trailer<br />

FR-LTW-EXP06-<br />

54


Billing records of all Forest River<br />

Defense Experts<br />

All photographs taken by Forest River<br />

and/or Forest River’s Experts<br />

Any document to be identified by<br />

Defendant Forest River in the ongoing<br />

discovery and deposition process<br />

Any Forest River supplementation of<br />

any report and supplementing documents<br />

which may occur<br />

Any and all Forest River demonstrative<br />

aids for trial to be exchanged at the<br />

appropriate time<br />

U.S.A.<br />

262. U.S.A. / FEMA Disaster File for Bobbi<br />

Wright and/or Lyndon Wright<br />

55<br />

017166;<br />

FR-LTW-EXP06-<br />

017925-<br />

FR-LTW-EXP06-017931<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

FEMA 124-000001-<br />

FEMA 124-000078<br />

263. Affidavits of Robert James, Ph.D. To be supplemented<br />

264. Curriculum Vitae of Robert James, To be supplemented<br />

Ph.D.<br />

265. Reliance Materials and File of Robert To be supplemented<br />

James, Ph.D.<br />

266. Any and all Deposition Testimony of To be supplemented<br />

Robert James, Ph.D.<br />

267. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Robert James, Ph.D.<br />

268. Affidavits of Bruce Kelman, Ph.D. To be supplemented<br />

269. Curriculum Vitae of Bruce Kelman, To be supplemented<br />

Ph.D.<br />

270. Reliance Materials and File of Bruce To be supplemented<br />

Kelman, Ph.D.<br />

271. Any and all Deposition Testimony of To be supplemented<br />

Bruce Kelman, Ph.D.<br />

272. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Bruce Kelman, Ph.D.<br />

273. Affidavits of Michael Lindell, Ph.D. To be supplemented<br />

274. Curriculum Vitae of Michael Lindell, To be supplemented<br />

Ph. D.<br />

275. Reliance Materials and File of Michael To be supplemented<br />

Lindell, Ph.D.<br />

276. Any and all Deposition Testimony of To be supplemented


Michael Lindell, Ph.D.<br />

277. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Michael Lindell, Ph.D.<br />

278. Affidavits of Richard Monson, M.D., To be supplemented<br />

Sc.D.<br />

279. Curriculum Vitae of Richard Monson, To be supplemented<br />

M.D., Sc.D.<br />

280. Reliance Materials and File of Richard To be supplemented<br />

Monson, M.D., Sc.D.<br />

281. Any and all Deposition Testimony of To be supplemented<br />

Richard Monson, M.D., Sc.D.<br />

282. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Richard Monson, M.D.,<br />

Sc.D.<br />

283. Affidavits of Mark Polk To be supplemented<br />

284. Curriculum Vitae of Mark Polk To be supplemented<br />

285. Reliance Materials and File of Mark To be supplemented<br />

Polk<br />

286. Any and all Deposition Testimony of To be supplemented<br />

Mark Polk<br />

287. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Mark Polk<br />

288. Affidavits of Coreen Robbins, M.H.S., To be supplemented<br />

Ph.D., C.I.H.<br />

289. Curriculum Vitae of Coreen Robbins, To be supplemented<br />

M.H.S., Ph.D., C.I.H.<br />

290. Reliance Materials and File of Coreen To be supplemented<br />

Robbins, M.H.S., Ph.D., C.I.H.<br />

291. Any and all Deposition Testimony of To be supplemented<br />

Coreen Robbins, M.H.S., Ph.D., C.I.H.<br />

292. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Coreen Robbins,<br />

M.H.S., Ph.D., C.I.H.<br />

293. Any and all Deposition Testimony of Dr. To be supplemented<br />

Christopher DeRosa<br />

294. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Dr. Christopher DeRosa<br />

295. FEMA Storage Site<br />

To be supplemented<br />

Duties/Responsibilities regarding Forest<br />

River, Inc.<br />

296. FEMA Model Travel Trailer<br />

To be supplemented<br />

Procurement Specifications dated 08-12-<br />

2004 (HSFE04-04-Q-800)<br />

297. FEMA Accessible Model Travel Trailer To be supplemented<br />

56


Procurement Specifications dated 04-21-<br />

2006 (with Accessible One Bedroom<br />

Travel Trailer Floor plan)<br />

298. “Important Information for Travel<br />

Trailer Occupants” FEMA brochure<br />

299. FEMA Model Travel Trailer<br />

Procurement Specifications Dated: July<br />

14, 2005<br />

300. Declaration of Kevin Souza, former<br />

Acting Deputy Director of Individual<br />

Assistance Division of FEMA<br />

301. “FEMA Storage Site<br />

Duties/Responsibilities”<br />

302. April 25, 2008 letter from FEMA to a<br />

THU occupant<br />

303. Summary of Test Results conducted by<br />

Weston Solutions, Inc. for the U.S. EPA<br />

304. Air Toxics, Ltd. Laboratory Narrative<br />

for samples submitted by Weston<br />

Solutions<br />

305. FEMA test results for <strong>formaldehyde</strong><br />

testing at FEMA THU staging areas<br />

during November 2005, December 2005,<br />

and January 2006<br />

306. FEMA Memorandum from May 31,<br />

2006 regarding Formaldehyde Air<br />

Sampling at the THU staging area in<br />

Purvis, Mississippi<br />

307. Email correspondence between FEMA<br />

and Government staff<br />

57<br />

PSC002350 –<br />

PSC002351<br />

PSC003049 –<br />

PSC003057<br />

PSC003058 –<br />

PSC003065<br />

PSC003092 –<br />

PSC003094<br />

PSC003397 –<br />

PSC003399<br />

PSC003407 –<br />

PSC003409<br />

PSC003410 –<br />

PSC003415<br />

PSC003416 –<br />

PSC003420<br />

PSC003421 –<br />

PSC003438<br />

PSC003439 –<br />

PSC003447<br />

308. FEMA Job Hazard Analysis Worksheet PSC023600<br />

309. FEMA Model Travel Trailer<br />

Procurement Specifications dated<br />

August 12, 2004<br />

310. New FEMA Procurement Specifications<br />

dated April 11, 2008 Release Number<br />

HQ-08-056<br />

311. FEMA Formaldehyde Timeline as of<br />

June 15, 2007<br />

312. FEMA Timeline as of August 7, 2008<br />

(From the deposition of Kevin Souza,<br />

FEMA Representative)<br />

313. FEMA Procedure Storage Site Manual<br />

Fall 2005<br />

FOREST-0002503 –<br />

FOREST-0002508<br />

PSC023601 –<br />

PSC023686<br />

PSC023687 –<br />

PSC023689<br />

PSC023690 –<br />

PSC023702<br />

To be supplemented


314. Dept of Homeland Security-Office of<br />

Inspector General-Hurricane Katrina<br />

Temporary Housing Technical<br />

Assistance Contracts- August 20, 2008<br />

(Internal Audit: OIG-08-88)<br />

315. FEMA Myths & Facts: Travel Trailers-<br />

November 8, 2007<br />

316. FEMA media release: Katrina/Rita<br />

Housing Facts-January 29, 2008<br />

317. FEMA media release: FEMA’s Ongoing<br />

Response to Formaldehyde-February 12,<br />

2008<br />

318. FEMA media release: CDC Results of<br />

Formaldehyde Level Tests- February 14,<br />

2008<br />

319. FEMA media release: FEMA Plan of<br />

Action on Formaldehyde Findings to be<br />

Implemented Immediately-February 14,<br />

2008<br />

320. FEMA media release: FEMA Offering<br />

Formaldehyde Testing to Occupants of<br />

Trailers and Mobile Homes in Disasters<br />

Nationwide-February 22, 2008<br />

321. FEMA media release: FAQ: 2008<br />

Disaster Housing Plan – June 10, 2008<br />

322. FEMA Statement on Formaldehyde –<br />

July 9, 2008<br />

323. FEMA media release: Myths & Facts<br />

about FEMA Housing Following<br />

Katrina-May 26, 2008<br />

324. FEMA media release: New Task<br />

Contract Awarded for Temporary<br />

Housing Units-August 4, 2008<br />

325. FEMA media release: Frequently Asked<br />

Questions-October 27, 2008<br />

326. FEMA media release: Initial Indoor Air<br />

Quality Tests Results-November 14,<br />

2008<br />

327. FEMA media release: FAQ National<br />

Disaster Housing Strategy – January 16,<br />

2009<br />

328. FEMA Statement on Travel Trailers and<br />

Formaldehyde<br />

58<br />

PSC023835 –<br />

PSC023863<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

PSC023795<br />

329. Email from Christopher DeRosa to PSC023796


Howard Frumkin on February 27, 2007<br />

330. Correspondence from Christopher<br />

DeRosa to Patrick Preston on February<br />

27, 2007<br />

331. Email from Christopher DeRosa to<br />

Howard Frumkin and Thomas Sinks on<br />

March 9, 2007<br />

332. Email from Christopher DeRosa to Mike<br />

Groutt on August 10, 2007<br />

333. Comments on Chro<strong>no</strong>logy of FEMA<br />

Trailers, drafted by Christopher DeRosa<br />

334. Correspondence from Christopher<br />

DeRosa to Howard Frumkin on<br />

September 21, 2007<br />

335. Email from Thomas Sinks to All CDC<br />

on October 12, 2007<br />

336. NCEH/ATSDR Procedures regarding<br />

Official Interaction with Persons or<br />

organization outside of NCEH/ATSDR<br />

59<br />

PSC023797<br />

PSC023798 –<br />

PSC023799<br />

PSC023800<br />

PSC023801<br />

PSC023802 –<br />

PSC023808<br />

PSC023809<br />

PSC023810 –<br />

PSC023811<br />

337. Logbook of Joseph Little To be supplemented<br />

338. Email from Patrick Preston to Scott To be supplemented<br />

Wright on November 30, 2005<br />

339. Email from Scott Wright and Joseph<br />

Little to Richard Nikel, et al., on<br />

December 7, 2006<br />

To be supplemented<br />

340. Correspondence between Barbara<br />

Rogers to Angela Davis and Sascha<br />

Fielding on March 21, 2007<br />

341. Email of Mary Margaret Walker<br />

(FEMA-WAXMAN-7-26-07 Production<br />

– 485)<br />

342. Correspondence From Mark Keim to<br />

Patrick Preston on March 17, 2007<br />

343. Correspondence from Patrick Preston to<br />

Scott Wright on November 30, 2005<br />

344. Email between Sam Coleman, Joseph<br />

Little and Scott Wright on December 1,<br />

2006<br />

345. Correspondence from Mark Keim to<br />

Patrick Preston on February 1, 2007<br />

346. Email to and from Philip Allred on<br />

February 15, 2007<br />

347. Email from Anne Sowell to Mark<br />

Bashor on August 8, 2007<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

PSC023819 –<br />

PSC023821<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented


348. Email between Patrick Preston and To be supplemented<br />

Margaret Ramos on February 27, 2007<br />

349. Email between David Chawaga and To be supplemented<br />

Mary Margaret Walker on May 1, 2007<br />

350. FEMA: Interim Direction on use of<br />

Temporary Housing Units (Revision<br />

PSC023828 –<br />

PSC023834<br />

Effective Date: March 10, 2008)<br />

. FEMA: FEMA Begins Next Phase of To be supplemented<br />

Inventory Reduction of Excess<br />

Temporary Housing Units<br />

352. “FEMA: Important Formaldehyde FEMA09-000388<br />

Information from FEMA Housing<br />

Occupants:<br />

353. “FEMA Travel Trailer Requirements” PSC0261671<br />

354. Any and all documents produced by Dr. To be supplemented<br />

Christopher DeRosa at his deposition,<br />

which will be taken/has been taken, or<br />

used as exhibits thereto<br />

355. Flyer: “CDC will test Trailers and To be supplemented<br />

Mobile Homes for Formaldehyde for<br />

CDC Partners such as Community<br />

Organizations in Louisiana and<br />

Mississippi” dated December 2007<br />

356. Script for Formaldehyde Concerns in To be supplemented<br />

Temporary Housing Unit: IA recipients<br />

with questions about <strong>formaldehyde</strong>, July<br />

2007<br />

357. Applicants Reporting MH/TT<br />

To be supplemented<br />

Formaldehyde Issues: IA recipients with<br />

questions about <strong>formaldehyde</strong>, July 2007<br />

358. Lottie Travel Trailer (Receiving) To be supplemented<br />

Inspection Checklist<br />

359. FEMA Brochure: “Important<br />

To be supplemented<br />

Information for Travel Trailer<br />

Occupants”<br />

360. FEMA: Important Formaldehyde To be supplemented<br />

Information for FEMA Housing<br />

Occupants<br />

361. Email from Martin McNeese dated To be supplemented<br />

October 11, 2006<br />

362. Email from Curtis Melnick dated May To be supplemented<br />

11, 2006<br />

363. Memo from FEMA Temporary Housing<br />

Agent Group: Occupants with questions<br />

To be supplemented<br />

60


about Formaldehyde regarding<br />

Formaldehyde-Help-line Calls, Referrals<br />

and Transfers dated July 2007<br />

364. FEMA Internal documents regarding<br />

<strong>formaldehyde</strong><br />

365. Emails regarding Katrina and Rita<br />

housing estimates dated November 1,<br />

2005<br />

366. Assessment of health Complaints among<br />

Pediatric Residents of FEMA-Supplied<br />

Trailers and Mobile Homes in Hancock<br />

County, Mississippi (Exhibit from the<br />

deposition of Michael Lapinski)<br />

367. Fact Sheet: Assessment of Health<br />

Complaints Among Children Living in<br />

FEMA Temporary Housing Units in<br />

Hancock county, Mississippi (Exhibit<br />

from the deposition of Michael<br />

Lapinski)<br />

Emails re: Formaldehyde<br />

Formaldehyde Flyer<br />

61<br />

To be supplemented<br />

To be supplemented<br />

Lapinski<br />

Exhibit 17<br />

Lapinski<br />

Exhibit 16<br />

To be supplemented<br />

To be supplemented<br />

Request for Proposal re: Travel Trailers FR 3522<br />

To be supplemented<br />

368. Any and all documentation and/or<br />

exhibits identified by defendant’s<br />

experts and/or fact witness in the<br />

preparation of their reports and/or<br />

testimony.<br />

369. Any and all exhibits identified and/or<br />

used and/or relied upon by defendant’s<br />

in the ongoing litigation of this matter.<br />

Shaw<br />

Billing records of all <strong>US</strong>A / FEMA<br />

Defense Experts<br />

Any photographs taken by <strong>US</strong>A / FEMA<br />

and/or <strong>US</strong>A / FEMA defense experts<br />

Any document to be identified by<br />

Defendant <strong>US</strong>A / FEMA in the ongoing<br />

discovery and deposition process<br />

Any <strong>US</strong>A / FEMA supplementation of<br />

any report and supplementing documents<br />

which may occur<br />

Any and all <strong>US</strong>A / FEMA demonstrative<br />

aids for trial to be exchanged at the<br />

appropriate time<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented


Environmen<br />

tal<br />

370. Any and all Class certification Shaw<br />

Environmental deposition testimony<br />

371. Any and all Class certification Shaw<br />

Environmental deposition exhibits /<br />

documents produced<br />

372. Shaw Environmental unit file on Lyndon<br />

Wright <strong>trailer</strong><br />

62<br />

To be supplemented<br />

To be supplemented<br />

SHAW WRI-00001-<br />

SHAW WRI-00017<br />

Entergy Orleans Meter Data SHAW-WRI 00051<br />

Shaw Standard Operating Procedure<br />

Trailer Processing and Yard Inspection<br />

dated 2/1/06<br />

SHAW 013564-<br />

SHAW 013568<br />

CH2M Hill, Inc., FEMA Trailer User’s SHAW 013523-<br />

Guide<br />

SHAW 013538<br />

373. Shaw / FEMA contract To be supplemented<br />

IA / TAC Contract SHAW 001890-<br />

SHAW 002019<br />

FEMA Request for Proposal Contract SHAW 000373<br />

HSFEHQ-05-0573<br />

SHAW 000578<br />

Checklists / PMI form SHAW 013303<br />

Picture of Installed Trailer SHAW 002517<br />

TT/MH QC Construction Issues/Maint SHAW 002363-<br />

Issues Sheet<br />

SHAW 002364<br />

Shaw Code emails and communications To be supplemented<br />

Orleans Parish Motion SHAW 002099-<br />

SHAW 003912<br />

Kenner Ordinance SHAW 003932-<br />

SHAW 003934<br />

Gretna & Westwego Ordinance SHAW 003930-<br />

SHAW 003931<br />

Communications with Subs re:<br />

implementation of Emergency Housing<br />

Contract (to be identified)<br />

C. Martin Documents (and other transfer<br />

documents)<br />

To be supplemented<br />

SHAW 000042-<br />

SHAW 000051;<br />

LW-CMC-000001-<br />

LW-CMC-000071<br />

Crown Roofing Services Documents CROWN 000001-<br />

CROWN 000016<br />

July 19, 2006 Work Plan SHAW 000669-<br />

SHAW 000700<br />

Pier Construction SHAW 002416<br />

Shaw Emails relating to Formaldehyde SHAW 013510;


SHAW 013511-<br />

SHAW 013512;<br />

SHAW 013513-<br />

SHAW 013514;<br />

SHAW 013515-<br />

SHAW013516;<br />

SHAW 013517-<br />

SHAW 013518;<br />

SHAW 013519-<br />

SHAW 013520;<br />

SHAW 013521-<br />

SHAW 013522;<br />

SHAW 013539-<br />

SHAW 013545;<br />

SHAW 013546-<br />

SHAW 013547;<br />

SHAW 013548-<br />

SHAW 013549;<br />

SHAW 013554;<br />

SHAW 013555-<br />

SHAW 013556;<br />

SHAW 013557;<br />

SHAW 013558-<br />

SHAW 013559;<br />

SHAW 013560-<br />

SHAW 013562<br />

Shaw Email: Burgess to Goetz, SHAW 002257-<br />

10/18/05<br />

SHAW 002259<br />

9:51 a.m.<br />

Shaw Email: Burgess to Goetz, 10/18/05<br />

2:48 p.m.<br />

SHAW 002260-<br />

SHAW 002263<br />

Shaw Email: Miller to Burgess, 11/29/05 SHAW 003145-<br />

SHAW 003147<br />

Shaw Email: Miller to Burgess, 11/22/05 SHAW 003058<br />

Shaw Email: Black to Janz, 11/11/05 SHAW 002773-<br />

SHAW 002796<br />

Shaw Email: Neal to Janz, 02/03/06 SHAW 005015-<br />

SHAW 005016<br />

Shaw Email: Orris to Brixius, 10/19/05 SHAW 002302-<br />

SHAW 002303<br />

Shaw Email: Janz to Smiley, 07/06/06 SHAW 011024-<br />

SHAW 011025<br />

Shaw Policies and Clarifications SHAW 002726-<br />

SHAW 002727<br />

63


Shaw Group Suggested Call Center<br />

Questionnaire<br />

SHAW 013236-<br />

SHAW 013237<br />

Haul & Install Call Center Questionnaire SHAW 013238-<br />

SHAW 013240<br />

Do Not Lease Document SHAW 003267<br />

Shaw Task Order 05-0006 Site SHAW 000601-<br />

Identification<br />

SHAW 000615<br />

Shaw Task Order No. 014 Trailer<br />

Transportation<br />

SHAW 000631-<br />

SHAW 000632<br />

Final Draft Work Order, March 19, 2006 SHAW 000900-<br />

SHAW 000939<br />

Final Group Site Work Plan, April 2006 SHAW 000952-<br />

SHAW 000992<br />

June 8, 2006, Work Plan SHAW 000746-<br />

SHAW 000786<br />

June 14, 2006 City Park Trailer Park SHAW 001054-<br />

SHAW 001089<br />

Final Work Order on Group Sites, June<br />

26, 2006<br />

SHAW 001102-<br />

SHAW 001142<br />

Shaw Inspection Protocol (2 pages) To be supplemented<br />

Demobilization Documents SHAW 002316-<br />

SHAW 002317<br />

374. All FEMA task orders to Shaw To be supplemented<br />

Environmental<br />

375. All FEMA extension of time orders to To be supplemented<br />

Shaw Environmental<br />

All <strong>formaldehyde</strong> emails and documents To be supplemented<br />

RCG Contract Documents<br />

376. All FEMA Amendments or<br />

Modifications to Shaw Environmental<br />

contract<br />

64<br />

To be supplemented<br />

To be supplemented<br />

377. All Shaw Environmental work plans To be supplemented<br />

produced to Plaintiff<br />

378. Subcontractor agreement with installer To be supplemented<br />

of Wright unit<br />

379. Affidavits of John D. Osteraas To be supplemented<br />

380. Curriculum Vitae of John D. Osteraas To be supplemented<br />

381. Reliance Materials and File of John D. To be supplemented<br />

Osteraas<br />

382. Any and all Deposition Testimony of To be supplemented<br />

John D. Osteraas<br />

383. Any and all Exhibits from the To be supplemented<br />

deposition(s) of John D. Osteraas<br />

384. Any and all Deposition Testimony of To be supplemented


Corporate Representative of Shaw<br />

Environmental, yet to be designated<br />

385. Any and all Exhibits from the<br />

deposition(s) of Corporate<br />

Representative of Shaw Environmental,<br />

yet to be designated<br />

386. Any and all Deposition Testimony of<br />

Project Manager of Shaw<br />

Environmental, yet to be designated<br />

387. Any and all Exhibits from the<br />

deposition(s) of Project Manager of<br />

Shaw Environmental, yet to be<br />

designated<br />

388. Any and all additional documents <strong>no</strong>t yet<br />

produced in this matter<br />

389. Any and all documentation and/or<br />

exhibits identified by defendant’s<br />

experts and/or fact witness in the<br />

preparation of their reports and/or<br />

testimony.<br />

390. Any and all exhibits identified and/or<br />

used and/or relied upon by defendant’s<br />

in the ongoing litigation of this matter.<br />

Billing records of all Shaw<br />

Environmental Defense Experts<br />

Any photographs taken by Shaw<br />

Environmental and/or Shaw<br />

Environmental defense experts<br />

Any Shaw Environmental<br />

supplementation of any report and<br />

supplementing documents which may<br />

occur<br />

Any document to be identified by<br />

Defendant Shaw Environmental in the<br />

ongoing discovery and deposition<br />

process<br />

Any and all Shaw Environmental<br />

demonstrative aids for trial to be<br />

exchanged at the appropriate time<br />

Wright Unit<br />

391. Photographs taken by or in the<br />

possession of Wright of the Forest River,<br />

Inc., unit<br />

Photographs of Lyndon Wright with<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

65


Trailer<br />

392. Any and all labels or stickers on the<br />

Forest River, Inc., unit occupied by<br />

Lyndon Wright<br />

Billing records of all Shaw<br />

Environmental Defense Experts<br />

All photographs taken by Shaw<br />

Environmental<br />

Wright File<br />

393. Photographs of Lyndon Wright<br />

regarding skin conditions<br />

66<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

394. Lyndon Wright Financial Records To be supplemented<br />

395. Lyndon Wright Employment Records To be supplemented<br />

Employment Records from the City of<br />

New Orleans related to Lyndon Wright<br />

LW-CITY NO00001-<br />

00256<br />

Attendance Records from City of New<br />

Orleans and Hyatt New Orleans relating<br />

to Lyndon Wright<br />

LW-CITY NO 00001-<br />

00256 & LW-<br />

HYATT00001-00126<br />

Lyndon Wright Original Complaint<br />

Lyndon Wright Amended Complaint<br />

Lyndon Wright Plaintiff Fact Sheet<br />

Lyndon Wright Amended Plaintiff Fact<br />

Sheet<br />

Medical<br />

Records<br />

396. Medical Records from Dr. Farber,<br />

Kenner Dermatology / Gulf South<br />

Medical and Surgical Institute regarding<br />

Lyndon Wright<br />

Photographs of Lyndon Wright from the<br />

records of Kenner Dermatology<br />

Medical Records from East Jefferson<br />

General Hospital regarding Lyndon<br />

Wright<br />

397. Medical Records from Dr. Worley<br />

regarding Lyndon Wright<br />

398. Medical Records from Uptown<br />

Nephrology regarding Lyndon Wright<br />

399. Medical Records from Dr. Richard<br />

Spector regarding Lyndon Wright<br />

Medical Records from Dr. Kenneth<br />

Smith regarding Lyndon Wright<br />

Medical Records of Dr. H. James<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

LWFR-EXP2-000021-<br />

LWFR-EXP2-000052<br />

LWFR-EXP2-000010-<br />

LWFR-EXP2-000020<br />

LWFR-EXP15-000518-<br />

LWFR-EXP15-000522;<br />

LW-EJGH0001-<br />

LW-EJGH00041<br />

LWFR-EXP14-000255-<br />

LWFR-EXP14-000256<br />

LWFW-EXP14-000085-<br />

LWFW-EXP14-000254<br />

LWFR-EXP14-000008-<br />

LWFR-EXP14-000084<br />

LTW-EXP07-000250<br />

LTW-EXP07-000291<br />

To be supplemented


Wedner<br />

Touro Medical Records<br />

Dr. Shwery administered psychological<br />

testing data<br />

Dr. Thompson / Dr. Mangu<strong>no</strong>-Mire<br />

psychological testing<br />

Report of Gina Mangu<strong>no</strong>-Mire<br />

400. Rite Aid Pharmacy Records regarding<br />

Lyndon Wright<br />

Walgreens Pharmacy Records regarding<br />

Lyndon Wright<br />

Others<br />

Demonstrative wood panels removed<br />

from the Lyndon Wright Trailer<br />

Demonstrative Samples of No<br />

Formaldehyde Added wood composite<br />

products<br />

401. Any and all Deposition Testimony of<br />

Representative of NACS, yet to be<br />

designated<br />

402. Any and all Exhibits from the<br />

deposition(s) of Representative of<br />

NACS, yet to be designated<br />

403. Any and all Deposition Testimony of<br />

Representative of RVIA, yet to be<br />

designated<br />

404. Any and all Exhibits from the<br />

deposition(s) of Representative of<br />

RVIA, yet to be designated<br />

Any and all Deposition Testimony of<br />

Representative of Lippert Components,<br />

yet to be designated<br />

Any and all Exhibits from the<br />

deposition(s) of Representative of<br />

LWFR-EXP12-000040-<br />

LWFR-EXP12-000046;<br />

LWFR-EXP12-000150-<br />

LWFR-EXP12-000153<br />

LWFR-EXP12-000289-<br />

LWFR-EXP12-000312;<br />

LWFR-EXP12-000512-<br />

LWFR-EXP12-000519<br />

FR-LTW-EXP08-<br />

002224-<br />

FR-LTW-EXP08-002258<br />

To be supplemented<br />

FR-LTW-EXP08-<br />

002259-<br />

FR-LTW-EXP08-002261<br />

LWFR-EXP12-000279-<br />

LWFR-EXP12-000286<br />

LWFR-EXP12-000485-<br />

LWFR-EXP12-000509<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

67


Lippert Components, yet to be<br />

designated<br />

Any and all Deposition Testimony of<br />

Representative of RCG Enterprises, yet<br />

to be designated<br />

Any and all Exhibits from the<br />

deposition(s) of Representative of RCG<br />

Enterprises, yet to be designated<br />

Louisiana State Board of Medical<br />

Examiners Temporary Permit<br />

Qualifications/Instructions<br />

BlueLinx Corporation: Material Safety<br />

Data Sheet for urea Formaldehyde<br />

Bonded Wood Products<br />

Georgia-Pacific: Material Safety Data<br />

Sheet for Urea Formaldehyde Bonded<br />

Wood Products<br />

Louisiana Pacific: Material Safety Data<br />

Sheet for Urea Formaldehyde Bonded<br />

Panel Products<br />

Lippert Component Frame Design for<br />

32BHLE units<br />

Georgia Pacific: Material Safety Data<br />

Sheet #30 for UF Bonded Wood<br />

Products<br />

Georgia Pacific: Material Safety Data<br />

Sheet #31 for Wood and Wood Products<br />

Manufactured Home Decking Labels<br />

from Georgia Pacific<br />

City of New Orleans Environmental<br />

testing results and report responsive to<br />

Forest River, Inc., subpoena<br />

Any photographs and/or videos taken by<br />

Scott Johnson of the Testing of the<br />

Forest River Unit<br />

Any and all documentation and/or<br />

exhibits identified by defendant’s<br />

experts and/or fact witness in the<br />

preparation of their reports and/or<br />

testimony.<br />

Any document necessary for rebuttal<br />

Any and all exhibits and/or documents<br />

identified and/or used and/or relied upon<br />

by defendant’s in the ongoing litigation<br />

To be supplemented<br />

To be supplemented<br />

PSC026167 –<br />

PSC026172<br />

PSC003068 –<br />

PSC003078<br />

PSC003079 –<br />

PSC003091<br />

FLE00006354<br />

To be supplemented<br />

GAPAC-000001 –<br />

GAPAC-000006<br />

GAPAC-000007 –<br />

GAPAC-000011<br />

GAPAC-000012 –<br />

GAPAC-000014<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

68


of this matter.<br />

Any and all deposition testimony and/or<br />

documents or exhibits introduced at any<br />

deposition of plaintiff’s and/or<br />

defendants’ experts<br />

Any and all plaintiff and/or defendants<br />

expert reports, both preliminary and<br />

final, submitted and anticipated to be<br />

submitted including all reliance<br />

materials.<br />

To be supplemented<br />

To be supplemented<br />

Plaintiff respectfully reserves the right to utilize any exhibit listed by any other party or<br />

utilized as an exhibit in the depositions taken in this matter. Plaintiff further respectfully<br />

reserves the right to supplement and amend this list once discovery is complete.<br />

CERTIFICATE OF SERVICE<br />

RESPECTFULLY SUBMITTED:<br />

FRANK J. D’AMICO, JR., APLC<br />

BY: s/Frank J. D’Amico, Jr.<br />

FRANK J. D’AMICO, JR., T.A. (#17519)<br />

AARON Z. AHLQUIST (#29063)<br />

FRANK J. D’AMICO, JR., APLC<br />

622 Baronne Street<br />

New Orleans, LA 70113<br />

Telephone: (504) 525-7272<br />

Fax: (504) 525-952<br />

I hereby certify that on January 12, 2010, I electronically filed the foregoing with the<br />

Clerk of <strong>Court</strong> by using the CM/ECF system which will send a <strong>no</strong>tice of electronic filing to all<br />

counsel of record who are CM/ECF participants. I further certify that I mailed the foregoing<br />

document and the <strong>no</strong>tice of electronic filing by first-class mail to all counsel of record who are<br />

<strong>no</strong>n-CM/ECF participants.<br />

s/Frank J. D’Amico<br />

FRANK J. D’AMICO, #17519<br />

69

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!